Areas of Biological and Technical Advances Driving Neurosurgical Innovation

Section III - Areas of Biological and Technical Advances Driving Neurosurgical Innovation

Published online by Cambridge University Press: 29 November 2025

Edited by

Benjamin Hartley ,

Philip E. Stieg ,

Rohan Ramakrishna and

Michael L. J. Apuzzo

Show author details

Benjamin Hartley: Affiliation:
Weill Cornell Medical Center
Philip E. Stieg: Affiliation:
Weill Cornell Medical College
Rohan Ramakrishna: Affiliation:
Weill Cornell Medical College
Michael L. J. Apuzzo: Affiliation:
Adjunct of Yale Medical School and Weill Cornell Medical College

Book contents

Get access

Information

Type: Chapter
Information: Neurosurgery
Beyond the Cutting Edge
, pp. 97 - 208

DOI: https://doi.org/10.1017/9781009597852 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Weaver, W. Molecular biology: origin of the term. Science. 1970;170(3958):581–2.10.1126/science.170.3958.581.bCrossRef Google Scholar PubMed

McCarty, M, Avery, OT. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: III. An improved method for the isolation of the transforming substance and its application to pneumococcus types II, III, and VI. The Journal of Experimental Medicine. 1946;83(2):97.10.1084/jem.83.2.97CrossRef Google Scholar

Chargaff, E. Chemical specificity of nucleic acids and mechanism of their enzymatic degradation. Experientia. 1950;6(6):201–9.CrossRef Google Scholar PubMed

Watson, JD, Crick, FH. Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature. 1953;171(4356):737–8.CrossRef Google Scholar PubMed

Crick, FH, editor. On protein synthesis. Symposium of the Society of Experimental Biology. 1958.Google Scholar

Worgall, S, Sondhi, D, Hackett, NR, Kosofsky, B, Kekatpure, MV, Neyzi, N, et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Human Gene Therapy. 2008;19(5):463–74.10.1089/hum.2008.022CrossRef Google Scholar

De, BP, Rosenberg, JB, Selvan, N, Wilson, I, Yusufzai, N, Greco, A, et al. Assessment of safety and biodistribution of AAVrh. 10hCLN2 following intracisternal administration in nonhuman primates for the treatment of CLN2 Batten disease. Human Gene Therapy. 2023;34(17–18):905–16.10.1089/hum.2023.067CrossRef Google Scholar PubMed

Bremova-Ertl, T, Hofmann, J, Stucki, J, Vossenkaul, A, Gautschi, M. Inborn errors of metabolism with ataxia: current and future treatment options. Cells. 2023;12(18):2314.CrossRef Google Scholar PubMed

Biffi, A, Montini, E, Lorioli, L, Cesani, M, Fumagalli, F, Plati, T, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341(6148):1233158.10.1126/science.1233158CrossRef Google Scholar PubMed

Fumagalli, F, Calbi, V, Sora, MGN, Sessa, M, Baldoli, C, Rancoita, PMV, et al. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access. The Lancet. 2022;399(10322):372–83.10.1016/S0140-6736(21)02017-1CrossRef Google Scholar PubMed

National Human Genome Research Institute. The cost of sequencing a human genome 2024 [updated Nov 2021]. Available from: https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost.Google Scholar

Parsons, DW, Jones, S, Zhang, X, Lin, JC-H, Leary, RJ, Angenendt, P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807–12.10.1126/science.1164382CrossRef Google Scholar PubMed

Kanamori, M, Kikuchi, A, Watanabe, M, Shibahara, I, Saito, R, Yamashita, Y, et al. Rapid and sensitive intraoperative detection of mutations in the isocitrate dehydrogenase 1 and 2 genes during surgery for glioma. Journal of Neurosurgery. 2014;120(6):1288–97.CrossRef Google Scholar

Patel, T, Bander, ED, Venn, RA, Powell, T, Cederquist, GY-M, Schaefer, PM, et al. The role of extent of resection in IDH1 wild-type or mutant low-grade gliomas. Neurosurgery. 2018;82(6):808.CrossRef Google Scholar PubMed

Rouleau, GA, Merel, P, Lutchman, M, Sanson, M, Zucman, J, Marineau, C, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993;363(6429):515–21.10.1038/363515a0CrossRef Google Scholar

Gregory, GE, Islim, AI, Hannan, CJ, Jones, AP, Hammerbeck-Ward, C, Rutherford, SA, et al. The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis. Neuro-oncology Advances. 2023;5(Supplement_1):i94–104.10.1093/noajnl/vdac127CrossRef Google Scholar PubMed

Thompson, EM, Hielscher, T, Bouffet, E, Remke, M, Luu, B, Gururangan, S, et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. The Lancet Oncology. 2016;17(4):484–95.10.1016/S1470-2045(15)00581-1CrossRef Google Scholar PubMed

Nobre, L, Zapotocky, M, Khan, S, Fukuoka, K, Fonseca, A, McKeown, T, et al. Pattern of relapse and treatment response in WNT-activated medulloblastoma. Cell Reports Medicine. 2020;1(3).10.1016/j.xcrm.2020.100038CrossRef Google Scholar PubMed

Brunklaus, A, Ellis, R, Reavey, E, Forbes, G, Zuberi, S. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain. 2012;135(8):2329–36.10.1093/brain/aws151CrossRef Google Scholar PubMed

Zhu, Y, Guignard, F, Zhao, D, Liu, L, Burns, DK, Mason, RP, et al. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell. 2005;8(2):119–30.10.1016/j.ccr.2005.07.004CrossRef Google Scholar PubMed

Pei, Y, Moore, CE, Wang, J, Tewari, AK, Eroshkin, A, Cho, Y-J, et al. An animal model of MYC-driven medulloblastoma. Cancer Cell. 2012;21(2):155–67.10.1016/j.ccr.2011.12.021CrossRef Google Scholar PubMed

Cunningham, K, Uchida, Y, O’Donnell, E, Claudio, E, Li, W, Soneji, K, et al. Conditional deletion of Ccm2 causes hemorrhage in the adult brain: a mouse model of human cerebral cavernous malformations. Human Molecular Genetics. 2011;20(16):3198–206.10.1093/hmg/ddr225CrossRef Google Scholar

Ripps, ME, Huntley, GW, Hof, PR, Morrison, JH, Gordon, JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences USA. 1995;92(3):689–93.10.1073/pnas.92.3.689CrossRef Google Scholar PubMed

Petrov, D, Mansfield, C, Moussy, A, Hermine, O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Frontiers in Aging Neurosciencez. 2017;9:68.Google Scholar PubMed

Mangiarini, L, Sathasivam, K, Seller, M, Cozens, B, Harper, A, Hetherington, C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87(3):493–506.10.1016/S0092-8674(00)81369-0CrossRef Google Scholar

Dean, M, Sung, VW. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington’s disease. Drug Design, Development and Therapy. 2018:313–19.CrossRef Google Scholar

Bonomo, R, Elia, AE, Bonomo, G, Romito, LM, Mariotti, C, Devigili, G, et al. Deep brain stimulation in Huntington’s disease: a literature review. Neurological Sciences. 2021;42(11):4447–57.10.1007/s10072-021-05527-1CrossRef Google Scholar PubMed

Rutka, JT, Taylor, M, Mainprize, T, Langlois, A, Ivanchuk, S, Mondal, S, et al. Molecular biology and neurosurgery in the third millennium. Neurosurgery. 2000;46(5):1034–51.10.1097/00006123-200005000-00002CrossRef Google Scholar PubMed

Van Aelst, L, Barr, M, Marcus, S, Polverino, A, Wigler, M. Complex formation between RAS and RAF and other protein kinases. Proceedings of the National Academy of Sciences. 1993;90(13):6213–17.CrossRef Google Scholar PubMed

Chardin, P, Camonis, JH, Gale, NW, Van Aelst, L, Schlessinger, J, Wigler, MH, et al. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science. 1993;260(5112):1338–43.10.1126/science.8493579CrossRef Google Scholar PubMed

Li, B, Fields, S. Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two‐hybrid system. The FASEB Journal. 1993;7(10):957–63.10.1096/fasebj.7.10.8344494CrossRef Google Scholar PubMed

Hannon, GJ, Demetrick, D, Beach, D. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes & Development. 1993;7(12a):2378–91.10.1101/gad.7.12a.2378CrossRef Google Scholar PubMed

Jinek, M, Chylinski, K, Fonfara, I, Hauer, M, Doudna, JA, Charpentier, E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–21.10.1126/science.1225829CrossRef Google Scholar PubMed

Platt, RJ, Chen, S, Zhou, Y, Yim, MJ, Swiech, L, Kempton, HR, et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014;159(2):440–55.CrossRef Google Scholar PubMed

Louis, DN, Perry, A, Wesseling, P, Brat, DJ, Cree, IA, Figarella-Branger, D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncology. 2021;23(8):1231–51.CrossRef Google Scholar PubMed

Reuss, DE. Updates on the WHO diagnosis of IDH-mutant glioma. Journal of Neuro-oncology. 2023:1–9.10.1007/s11060-023-04250-5CrossRef Google Scholar

Cahill, DP. Extent of resection of glioblastoma: a critical evaluation in the molecular era. Neurosurgery Clinics. 2021;32(1):23–9.Google Scholar PubMed

Jian, A, Jang, K, Manuguerra, M, Liu, S, Magnussen, J, Di Ieva, A. Machine learning for the prediction of molecular markers in glioma on magnetic resonance imaging: a systematic review and meta-analysis. Neurosurgery. 2021;89(1):31–44.10.1093/neuros/nyab103CrossRef Google Scholar PubMed

Hollon, T, Jiang, C, Chowdury, A, Nasir-Moin, M, Kondepudi, A, Aabedi, A, et al. Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging. Nature Medicine. 2023;29(4):828–32.10.1038/s41591-023-02252-4CrossRef Google Scholar PubMed

Vermeulen, C, Pagès-Gallego, M, Kester, L, Kranendonk, M, Wesseling, P, Verburg, N, et al. Ultra-fast deep-learned CNS tumour classification during surgery. Nature. 2023;622(7984):842–9.10.1038/s41586-023-06615-2CrossRef Google Scholar PubMed

Hegi, ME, Diserens, A-C, Gorlia, T, Hamou, M-F, De Tribolet, N, Weller, M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. New England Journal of Medicine. 2005;352(10):997–1003.10.1056/NEJMoa043331CrossRef Google Scholar PubMed

Zuccato, JA, Patil, V, Mansouri, S, Voisin, M, Chakravarthy, A, Shen, SY, et al. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification. Neuro-oncology. 2023; 25(8):1452–60.10.1093/neuonc/noac264CrossRef Google Scholar PubMed

Bunda, S, Zuccato, JA, Voisin, MR, Wang, JZ, Nassiri, F, Patil, V, et al. Liquid biomarkers for improved diagnosis and classification of CNS tumors. International Journal of Molecular Sciences. 2021;22(9):4548.10.3390/ijms22094548CrossRef Google Scholar PubMed

Mellinghoff, IK, van den Bent, MJ, Blumenthal, DT, Touat, M, Peters, KB, Clarke, J, et al. Vorasidenib in IDH1-or IDH2-mutant low-grade glioma. New England Journal of Medicine. 2023;389:589–601.10.1056/NEJMoa2304194CrossRef Google Scholar

Ramos, A, Giantini-Larsen, A, Pannullo, SC, Brandmaier, A, Knisely, J, Magge, R, et al. A multidisciplinary management algorithm for brain metastases. Neuro-Oncology Advances. 2022;4(1):vdac176.10.1093/noajnl/vdac176CrossRef Google Scholar PubMed

Malkki, H. Glioblastoma vaccine therapy disappointment in Phase III trial. Nature Reviews Neurology. 2016;12(4):190.10.1038/nrneurol.2016.38CrossRef Google Scholar PubMed

Carro, MS, Lim, WK, Alvarez, MJ, Bollo, RJ, Zhao, X, Snyder, EY, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010;463(7279):318–25.10.1038/nature08712CrossRef Google Scholar PubMed

Chang, SM, Wen, P, Cloughesy, T, Greenberg, H, Schiff, D, Conrad, C, et al. Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Investigational New Drugs. 2005;23:357–61.10.1007/s10637-005-1444-0CrossRef Google Scholar PubMed

Le Rhun, E, Preusser, M, Roth, P, Reardon, DA, van den Bent M, , Wen, P, et al. Molecular targeted therapy of glioblastoma. Cancer Treatment Reviews. 2019;80:101896.10.1016/j.ctrv.2019.101896CrossRef Google Scholar PubMed

Taylor, JW, Parikh, M, Phillips, JJ, James, CD, Molinaro, AM, Butowski, NA, et al. Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma. Journal of Neuro-oncology. 2018;140:477–83.10.1007/s11060-018-2977-3CrossRef Google Scholar PubMed

Weller, M, Butowski, N, Tran, DD, Recht, LD, Lim, M, Hirte, H, et al. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. The Lancet Oncology. 2017;18(10):1373–85.10.1016/S1470-2045(17)30517-XCrossRef Google Scholar

Marin, B-M, Porath, KA, Jain, S, Kim, M, Conage-Pough, JE, Oh, J-H, et al. Heterogeneous delivery across the blood–brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma. Neuro-oncology. 2021;23(12):2042–53.10.1093/neuonc/noab133CrossRef Google Scholar PubMed

Hainsworth, JD, Becker, KP, Mekhail, T, Chowdhary, SA, Eakle, JF, Wright, D, et al. Phase I/II study of bevacizumab with BKM120, an oral PI3 K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II). Journal of Neuro-Oncology. 2019;144:303–11.10.1007/s11060-019-03227-7CrossRef Google Scholar

Andrews, DW, Judy, KD, Scott, CB, Garcia, S, Harshyne, LA, Kenyon, L, et al. Phase Ib clinical trial of IGV-001 for patients with newly diagnosed glioblastoma. Clinical Cancer Research. 2021;27(7):1912–22.10.1158/1078-0432.CCR-20-3805CrossRef Google Scholar PubMed

Wennerberg, E, Vanpouille‐Box, C, Bornstein, S, Yamazaki, T, Demaria, S, Galluzzi, L. Immune recognition of irradiated cancer cells. Immunological Reviews. 2017;280(1):220–30.10.1111/imr.12568CrossRef Google Scholar PubMed

Liau, LM, Ashkan, K, Tran, DD, Campian, JL, Trusheim, JE, Cobbs, CS, et al. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine. 2018;16(1):1–9.Google Scholar PubMed

Preusser, M, van den Bent, MJ. Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana? Oxford University Press US; 2023;631–4.Google Scholar PubMed

Saha, D, Martuza, RL, Rabkin, SD. Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade. Oncoscience. 2017;4(7–8):67.10.18632/oncoscience.359CrossRef Google Scholar PubMed

Aghi, M, Martuza, RL. Oncolytic viral therapies – the clinical experience. Oncogene. 2005;24(52):7802–16.10.1038/sj.onc.1209037CrossRef Google Scholar PubMed

Nassiri, F, Patil, V, Yefet, LS, Singh, O, Liu, J, Dang, RM, et al. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Nature Medicine. 2023:1–9.10.1093/neuonc/noad179.0259CrossRef Google Scholar

Lu, VM, Shah, AH, Vallejo, FA, Eichberg, DG, Luther, EM, Shah, SS, et al. Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report. Neurosurgical Focus. 2021;50(2):E3.10.3171/2020.11.FOCUS20860CrossRef Google Scholar PubMed

Rojas, LA, Sethna, Z, Soares, KC, Olcese, C, Pang, N, Patterson, E, et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature. 2023:1–7.Google Scholar

Grabowski, MM, Sankey, EW, Ryan, KJ, Chongsathidkiet, P, Lorrey, SJ, Wilkinson, DS, et al. Immune suppression in gliomas. Journal of Neuro-oncology. 2021;151:3–12.10.1007/s11060-020-03483-yCrossRef Google Scholar PubMed

Sica, A, Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. The Journal of Clinical Investigation. 2012;122(3):787–95.CrossRef Google Scholar PubMed

Merola, A, Van Laar, A, Lonser, R, Bankiewicz, K. Gene therapy for Parkinson’s disease: contemporary practice and emerging concepts. Expert Review of Neurotherapeutics. 2020;20(6):577–90.10.1080/14737175.2020.1763794CrossRef Google Scholar PubMed

Tardieu, M, Zérah, M, Gougeon, M-L, Ausseil, J, de Bournonville, S, Husson, B, et al. Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial. The Lancet Neurology. 2017;16(9):712–20.10.1016/S1474-4422(17)30169-2CrossRef Google Scholar PubMed

References

Maehle, AH. Ambiguous cells: the emergence of the stem cell concept in the nineteenth and twentieth centuries. Notes Rec R Soc Lond. Dec 2011;65(4):359–78. doi:10.1098/rsnr.2011.0023CrossRef Google Scholar PubMed

Hansford, S, Huntsman, DG. Boveri at 100: Theodor Boveri and genetic predisposition to cancer. J Pathol. Oct 2014;234(2):142–5. doi:10.1002/path.4414CrossRef Google Scholar

Cooper, M. Regenerative pathologies: stem cells, teratomas and theories of cancer. Medicine Studies. 2009;1(1):55–66.10.1007/s12376-008-0002-4CrossRef Google Scholar

Paksoy, N, Askanazy, M. (1865–1940). In: van Krieken, JHJM, ed. Encyclopedia of Pathology. Springer International Publishing; 2016:1–5.Google Scholar

Dallenbach-Hellweg, G, Schmidt, D. History of gynecological pathology. VI. Jacob Felix Marchand. Int J Gynecol Pathol. Jul 1999;18(3):281–7. doi:10.1097/00004347-199907000-00016CrossRef Google Scholar PubMed

Cooper, B. The origins of bone marrow as the seedbed of our blood: from antiquity to the time of Osler. Proc (Bayl Univ Med Cent). Apr 2011;24(2):115–18. doi:10.1080/08998280.2011.11928697Google Scholar

Marino, M, Molinaro, M. Maximow, A A. (1874–1928). In: van Krieken, JHJM, ed. Encyclopedia of Pathology. Springer International Publishing; 2017:1–4.Google Scholar

Willier, BH. On the origin and differentiation of the sexual gland. The American Naturalist. 1933;67(711):298–305.10.1086/280492CrossRef Google Scholar

Pappenheim, Wormer E., Artur, , hematologist (1870–1916). 2001:52–3.Google Scholar

Capp, JP. Cancer stem cells: from historical roots to a new perspective. J Oncol. 2019;2019:5189232. doi:10.1155/2019/5189232CrossRef Google Scholar PubMed

Thomas, ED, Lochte, HL, Jr., Lu, WC, Ferrebee, JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. Sep 1957;257(11):491–6. doi:10.1056/nejm195709122571102CrossRef Google Scholar PubMed

Mathe, G, Amiel, JL, Schwarzenberg, L, et al. Successful allogenic bone marrow transplantation in man: chimerism, induced specific tolerance and possible anti-leukemic effects. Blood. Feb 1965;25:179–96.10.1182/blood.V25.2.179.179CrossRef Google Scholar PubMed

Lown, RN, Philippe, J, Navarro, W, et al. Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee. Bone Marrow Transplant. Jul 2014;49(7):880–6. doi:10.1038/bmt.2014.67CrossRef Google Scholar PubMed

De Robertis, EM. Spemann’s organizer and self-regulation in amphibian embryos. Nat Rev Mol Cell Biol. Apr 2006;7(4):296–302. doi:10.1038/nrm1855CrossRef Google Scholar PubMed

Eriksson, PS, Perfilieva, E, Björk-Eriksson, T, et al. Neurogenesis in the adult human hippocampus. Nat Med. Nov 1998;4(11):1313–27. doi:10.1038/3305CrossRef Google Scholar PubMed

Mirzadeh, Z, Merkle, FT, Soriano-Navarro, M, Garcia-Verdugo, JM, Alvarez-Buylla, A. Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell. Sep 2008;3(3):265–78. doi:10.1016/j.stem.2008.07.004CrossRef Google Scholar

Temple, S, Alvarez-Buylla, A. Stem cells in the adult mammalian central nervous system. Curr Opin Neurobiol. Feb 1999;9(1):135–41. doi:10.1016/s0959-4388(99)80017-8CrossRef Google Scholar PubMed

Apuzzo, ML, Neal, JH, Waters, CH, et al. Utilization of unilateral and bilateral stereotactically placed adrenomedullary-striatal autografts in parkinsonian humans: rationale, techniques, and observations. Neurosurgery. May 1990;26(5):746–57. doi:10.1097/00006123-199005000-00003CrossRef Google Scholar PubMed

Waters, CH, Itabashi, HH, Apuzzo, MLJ, Weiner, LP. Adrenal to caudate transplantation – postmortem study. Movement Disorders. 1990;5(3):248–50. doi:https://doi.org/10.1002/mds.870050312 CrossRef Google Scholar PubMed

Waters, CH, Apuzzo, ML, Neal, JH, Weiner, LP. Long-term follow-up of adrenal medullary transplantation for Parkinson’s disease. J Geriatr Psychiatry Neurol. Jan–Mar 1992;5(1):35–9. doi:10.1177/002383099200500106CrossRef Google Scholar PubMed

Lindvall, O, Rehncrona, S, Brundin, P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson’s disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol. Jun 1989;46(6):615–31. doi:10.1001/archneur.1989.00520420033021CrossRef Google Scholar PubMed

Lindvall, O, Brundin, P, Widner, H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson’s disease. Science. Feb 1990;247(4942):574–7. doi:10.1126/science.2105529CrossRef Google Scholar PubMed

Geron receives, FDA clearance to begin world’s first human clinical trial of embryonic stem cell-based therapy. MENLO PARK, Calif: Geron Corporation. 2009.Google Scholar

Pera, MF. Human embryo research and the 14-day rule. Development. Jun 2017;144(11):1923–5. doi:10.1242/dev.151191CrossRef Google Scholar PubMed

Cavaliere, G. A 14-day limit for bioethics: the debate over human embryo research. BMC Med Ethics. May 2017;18(1):38. doi:10.1186/s12910-017-0198-5CrossRef Google Scholar PubMed

Hyun, I, Bredenoord, AL, Briscoe, J, Klipstein, S, Tan, T. Human embryo research beyond the primitive streak. Science. Mar 2021;371(6533):998–1000. doi:10.1126/science.abf3751CrossRef Google Scholar PubMed

Ismaili M’hamdi, H, Rivron, NC, Asscher, EC. Going high and low: on pluralism and neutrality in human embryology policy-making. J Med Ethics. Dec 2022;doi:10.1136/jme-2022-108515CrossRef Google Scholar

Murugan, V. Embryonic stem cell research: a decade of debate from Bush to Obama. Yale J Biol Med. Sep 2009;82(3):101–3.Google Scholar PubMed

Omole, AE, Fakoya, AOJ. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications. PeerJ. 2018;6:e4370. doi:10.7717/peerj.4370CrossRef Google Scholar PubMed

Takahashi, K, Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. Aug 2006;126(4):663–76. doi:10.1016/j.cell.2006.07.024CrossRef Google Scholar PubMed

Soldner, F, Hockemeyer, D, Beard, C, et al. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. Mar 2009;136(5):964–77. doi:10.1016/j.cell.2009.02.013CrossRef Google Scholar PubMed

Dimos, JT, Rodolfa, KT, Niakan, KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. Aug 2008;321(5893):1218–21. doi:10.1126/science.1158799CrossRef Google Scholar PubMed

Dang, C GT, Surbone, A, et al. Cell proliferation. Holland-Frei Cancer Medicine, 6th ed. 2003.Google Scholar

Varzideh, F, Gambardella, J, Kansakar, U, Jankauskas, SS, Santulli, G. Molecular mechanisms underlying pluripotency and self-renewal of embryonic stem cells. Int J Mol Sci. May 2023;24(9). doi:10.3390/ijms24098386CrossRef Google Scholar PubMed

Barbouti, A, Evangelou, K, Pateras, IS, et al. In situ evidence of cellular senescence in Thymic Epithelial Cells (TECs) during human thymic involution. Mech Ageing Dev. Jan 2019;177:88–90. doi:10.1016/j.mad.2018.02.005CrossRef Google Scholar PubMed

Martínez-Cué, C, Rueda, N. Cellular senescence in neurodegenerative diseases. Front Cell Neurosci. 2020;14:16. doi:10.3389/fncel.2020.00016CrossRef Google Scholar PubMed

Isaković, J, Šerer, K, Barišić, B, Mitrečić, D. Mesenchymal stem cell therapy for neurological disorders: the light or the dark side of the force? Review. Front Bioeng Biotechnol. Feb 2023;11doi:10.3389/fbioe.2023.1139359CrossRef Google Scholar PubMed

Verma, M, Lizama, BN, Chu, CT. Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Translational Neurodegeneration. 2022;11(1):3. doi:10.1186/s40035-021-00278-7CrossRef Google Scholar PubMed

Wilson, DM, III, Cookson, MR, Van Den Bosch, L, Zetterberg, H, Holtzman, DM, Dewachter, I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693–714. doi:10.1016/j.cell.2022.12.032CrossRef Google Scholar PubMed

Guo, F, Liu, X, Cai, H, Le, W. Autophagy in neurodegenerative diseases: pathogenesis and therapy. Brain Pathol. Jan 2018;28(1):3–13. doi:10.1111/bpa.12545CrossRef Google Scholar PubMed

Chang, NC. Autophagy and stem cells: self-eating for self-renewal. review. Front Cell Develop Biol. March 2020;8. doi:10.3389/fcell.2020.00138CrossRef Google Scholar

García-Prat, L, Martínez-Vicente, M, Perdiguero, E, et al. Autophagy maintains stemness by preventing senescence. Nature. Jan 2016;529(7584):37–42. doi:10.1038/nature16187CrossRef Google Scholar PubMed

Mousaei Ghasroldasht, M, Seok, J, Park, HS, Liakath Ali, FB, Al-Hendy, A. Stem cell therapy: from idea to clinical practice. Int J Mol Sci. Mar 2022;23(5). doi:10.3390/ijms23052850CrossRef Google Scholar PubMed

Lukovic, D, Moreno Manzano, V, Stojkovic, M, Bhattacharya, SS, Erceg, S. Concise review: human pluripotent stem cells in the treatment of spinal cord injury. Stem Cells. Sep 2012;30(9):1787–92. doi:10.1002/stem.1159CrossRef Google Scholar PubMed

Digma, LA, Upadhyayula, PS, Martin, JR, Ciacci, JD. Chapter 31 – Stem cells and chronic spinal cord injury: Overview. In: Rajendram, R, Preedy, VR, Martin, CR, eds. Diagnosis and Treatment of Spinal Cord Injury. Academic Press; 2022:397–409.10.1016/B978-0-12-822498-4.00031-2CrossRef Google Scholar

Lin, C-C, Lai, S-R, Shao, Y-H, Chen, C-L, Lee, K-Z. The therapeutic effectiveness of delayed fetal spinal cord tissue transplantation on respiratory function following mid-cervical spinal cord injury. Neurotherapeutics. 2017;14(3):792–809. doi:10.1007/s13311-016-0509-4CrossRef Google Scholar PubMed

Pajer, K, Bellák, T, Nógrádi, A. Stem cell secretome for spinal cord repair: is it more than just a random baseline set of factors? Cells. Nov 2021;10(11). doi:10.3390/cells10113214CrossRef Google Scholar PubMed

Yang, D, Zhang, ZJ, Oldenburg, M, Ayala, M, Zhang, SC. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells. Jan 2008;26(1):55–63. doi:10.1634/stemcells.2007-0494CrossRef Google Scholar PubMed

Collier, TJ, Sortwell, CE, Daley, BF. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. J Neurosci. Jul 1999;19(13):5563–73. doi:10.1523/jneurosci.19-13-05563.1999CrossRef Google Scholar PubMed

Song, J-J, Oh, S-M, Kwon, O-C, et al. Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model. J Clin Invest. 2021;128(1). doi:10.1172/JCI93924Google Scholar

Zou, Y, Ma, D, Shen, H, et al. Aligned collagen scaffold combination with human spinal cord-derived neural stem cells to improve spinal cord injury repair. Biomaterials Sci. 2020;8(18):5145–5156. doi:10.1039/D0BM00431FCrossRef Google Scholar PubMed

Lara-Rodarte, R, Cortés, D, Soriano, K, et al. Mouse embryonic stem cells expressing GDNF show enhanced dopaminergic differentiation and promote behavioral recovery after grafting in parkinsonian rats. Front Cell Dev Biol. 2021;9:661656. doi:10.3389/fcell.2021.661656CrossRef Google Scholar PubMed

Oh, B, Santhanam, S, Azadian, M, et al. Electrical modulation of transplanted stem cells improves functional recovery in a rodent model of stroke. Nature Commun. 2022;13(1):1366. doi:10.1038/s41467-022-29017-wCrossRef Google Scholar

Perlow, MJ, Freed, WJ, Hoffer, BJ, Seiger, A, Olson, L, Wyatt, RJ. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science. May 1979;204(4393):643–7. doi:10.1126/science.571147CrossRef Google Scholar PubMed

Freed, WJ, Perlow, MJ, Karoum, F, et al. Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann Neurol. Nov 1980;8(5):510–19. doi:10.1002/ana.410080508CrossRef Google Scholar

Brundin, P, Barker, RA, Parmar, M. Neural grafting in Parkinson’s disease. Problems and possibilities. Prog Brain Res. 2010;184:265–94. doi:10.1016/s0079-6123(10)84014-2CrossRef Google Scholar

Di Santo, S, Seiler, S, Ducray, AD, Meyer, M, Widmer, HR. A subpopulation of dopaminergic neurons coexpresses serotonin in ventral mesencephalic cultures but not after intrastriatal transplantation in a rat model of Parkinson’s disease. Cell Transplant. Apr 2017;26(4):679–91. doi:10.3727/096368916x693707CrossRef Google Scholar PubMed

Tronci, E, Fidalgo, C, Carta, M. Foetal cell transplantation for Parkinson’s disease: focus on graft-induced dyskinesia. Parkinsons Dis. 2015;2015:563820. doi:10.1155/2015/563820Google Scholar PubMed

Lane, EL, Winkler, C, Brundin, P, Cenci, MA. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol Dis. May 2006;22(2):334–45. doi:10.1016/j.nbd.2005.11.011CrossRef Google Scholar PubMed

Spits, C, Mateizel, I, Geens, M, et al. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol. Dec 2008;26(12):1361–3. doi:10.1038/nbt.1510CrossRef Google Scholar PubMed

Martin, MJ, Muotri, A, Gage, F, Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med. Feb 2005;11(2):228–32. doi:10.1038/nm1181CrossRef Google Scholar PubMed

Frausin, S, Viventi, S, Verga Falzacappa, L, et al. Wharton’s jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem. 2015;117(4–5):329–38.10.1016/j.acthis.2015.02.005CrossRef Google Scholar PubMed

Hass, R, Kasper, C, Böhm, S, Jacobs, R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. May 2011;9:12. doi:10.1186/1478-811x-9-12CrossRef Google Scholar PubMed

Pittenger, MF, Mackay, AM, Beck, SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. Apr 1999;284(5411):143–7. doi:10.1126/science.284.5411.143CrossRef Google Scholar PubMed

Hofstetter, CP, Schwarz, EJ, Hess, D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA. Feb 2002;99(4):2199–204. doi:10.1073/pnas.042678299CrossRef Google Scholar PubMed

Salehi, H, Amirpour, N, Niapour, A, Razavi, S. An overview of neural differentiation potential of human adipose derived stem cells. Stem Cell Rev Rep. Feb 2016;12(1):26–41. doi:10.1007/s12015-015-9631-7CrossRef Google Scholar PubMed

Bai, WF, Zhang, Y, Xu, W, et al. Isolation and characterization of neural progenitor cells from bone marrow in cell replacement therapy of brain injury. Front Cell Neurosci. 2020;14:49. doi:10.3389/fncel.2020.00049CrossRef Google Scholar PubMed

Sandner, B, Ciatipis, M, Motsch, M, Soljanik, I, Weidner, N, Blesch, A. Limited functional effects of subacute syngeneic bone marrow stromal cell transplantation after rat spinal cord contusion injury. Cell Transplant. 2016;25(1):125–39. doi:10.3727/096368915x687679CrossRef Google Scholar PubMed

Deng, YB, Liu, XG, Liu, ZG, Liu, XL, Liu, Y, Zhou, GQ. Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys. Cytotherapy. 2006;8(3):210–14. doi:10.1080/14653240600760808CrossRef Google Scholar PubMed

Goutman, SA, Savelieff, MG, Sakowski, SA, Feldman, EL. Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials. Expert Opin Investig Drugs. Jun 2019;28(6):525–43. doi:10.1080/13543784.2019.1627324CrossRef Google Scholar PubMed

Nandoe Tewarie, RD, Hurtado, A, Ritfeld, GJ, et al. Bone marrow stromal cells elicit tissue sparing after acute but not delayed transplantation into the contused adult rat thoracic spinal cord. J Neurotrauma. Dec 2009;26(12):2313–22. doi:10.1089/neu.2009.0987Google Scholar

Dennis, JE, Charbord, P. Origin and differentiation of human and murine stroma. Stem Cells. 2002;20(3):205–14. doi:https://doi.org/10.1634/stemcells.20-3-205 CrossRef Google Scholar PubMed

Isern, J, García-García, A, Martín, AM, et al. The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function. Elife. Sep 2014;3:e03696. doi:10.7554/eLife.03696CrossRef Google Scholar PubMed

Dezawa, M, Kanno, H, Hoshino, M, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest. 2004;113(12):1701–10. doi:10.1172/JCI20935CrossRef Google Scholar PubMed

Boucherie, C, Schäfer, S, Lavand’homme, P, Maloteaux, JM, Hermans, E. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res. Jul 2009;87(9):2034–46. doi:10.1002/jnr.22038CrossRef Google Scholar

Rivera-Cruz, CM, Shearer, JJ, Figueiredo Neto, M, Figueiredo, ML. The immunomodulatory effects of mesenchymal stem cell polarization within the tumor microenvironment niche. Stem Cells Int. 2017;2017:4015039. doi:10.1155/2017/4015039CrossRef Google Scholar PubMed

Bai, L, Lennon, DP, Eaton, V, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. Aug 2009;57(11):1192–203. doi:10.1002/glia.20841CrossRef Google Scholar PubMed

Watanabe, S, Uchida, K, Nakajima, H, et al. Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment. Stem Cells. Jun 2015;33(6):1902–14. doi:10.1002/stem.2006CrossRef Google Scholar PubMed

Chen, J, Sanberg, PR, Li, Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. Nov 2001;32(11):2682–8. doi:10.1161/hs1101.098367CrossRef Google Scholar PubMed

Knippenberg, S, Thau, N, Schwabe, K, et al. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Neurodegen Dis. 2011;9(3):107–120. doi:10.1159/000331327CrossRef Google Scholar

Gnanasegaran, N, Govindasamy, V, Simon, C, et al. Effect of dental pulp stem cells in MPTP-induced old-aged mice model. Eur J Clin Invest. Jun 2017;47(6):403–414. doi:10.1111/eci.12753CrossRef Google Scholar PubMed

Nosrat, IV, Smith, CA, Mullally, P, Olson, L, Nosrat, CA. Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system. Eur J Neurosci. May 2004;19(9):2388–98. doi:10.1111/j.0953-816X.2004.03314.xCrossRef Google Scholar PubMed

Candelise, N, Santilli, F, Fabrizi, J, et al. The importance of stem cells isolated from human dental pulp and exfoliated deciduous teeth as therapeutic approach in nervous system pathologies. Cells. Jun 2023;12(13). doi:10.3390/cells12131686CrossRef Google Scholar PubMed

Nito, C, Sowa, K, Nakajima, M, et al. Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia. Biomed Pharmacother. Dec 2018;108:1005–14. doi:10.1016/j.biopha.2018.09.084CrossRef Google Scholar PubMed

Ullah, I, Park, JM, Kang, YH, et al. Transplantation of human dental pulp-derived stem cells or differentiated neuronal cells from human dental pulp-derived stem cells identically enhances regeneration of the injured peripheral nerve. Stem Cells Dev. Sep 2017;26(17):1247–1257. doi:10.1089/scd.2017.0068CrossRef Google Scholar PubMed

Serra, M, Brito, C, Correia, C, Alves, PM. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. Jun 2012;30(6):350–9. doi:10.1016/j.tibtech.2012.03.003CrossRef Google Scholar PubMed

Guha, P, Morgan, JW, Mostoslavsky, G, Rodrigues, NP, Boyd, AS. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell. Apr 2013;12(4):407–12. doi:10.1016/j.stem.2013.01.006CrossRef Google Scholar PubMed

Aron Badin, R, Bugi, A, Williams, S, et al. MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates. Nature Comm. Sep 2019;10(1):4357. doi:10.1038/s41467-019-12324-0CrossRef Google Scholar PubMed

Hargus, G, Cooper, O, Deleidi, M, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA. Sep 2010;107(36):15921–6. doi:10.1073/pnas.1010209107CrossRef Google Scholar PubMed

Wang, S, Zou, C, Fu, L, et al. Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson’s disease model. Cell Discovery. May 2015;1(1):15012. doi:10.1038/celldisc.2015.12CrossRef Google Scholar

Hiller, BM, Marmion, DJ, Thompson, CA, et al. Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease. NPJ Regenerative Medicine. April 2022;7(1):24. doi:10.1038/s41536-022-00221-yCrossRef Google Scholar PubMed

Pajer, K, Nemes, C, Berzsenyi, S, et al. Grafted murine induced pluripotent stem cells prevent death of injured rat motoneurons otherwise destined to die. Exp Neurol. Jul 2015;269:188–201. doi:10.1016/j.expneurol.2015.03.031CrossRef Google Scholar PubMed

Khazaei, M, Ahuja, CS, Fehlings, MG. Induced pluripotent stem cells for traumatic spinal cord injury. Front Cell Dev Biol. 2016;4:152. doi:10.3389/fcell.2016.00152Google Scholar PubMed

Kondo, T, Funayama, M, Tsukita, K, et al. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Reports. Aug 2014;3(2):242–9. doi:10.1016/j.stemcr.2014.05.017CrossRef Google Scholar PubMed

Kawai, H, Yamashita, T, Ohta, Y, et al. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab. Aug 2010;30(8):1487–93. doi:10.1038/jcbfm.2010.32CrossRef Google Scholar PubMed

Wellmerling, K, Lehmann, C, Singh, A, Kirby, BJ. Microfluidic chip for label-free removal of teratoma-forming cells from therapeutic human stem cells. J Immunol Regen Med. Dec 2020;10:100030. doi: https://doi.org/10.1016/j.regen.2020.100030 Google Scholar

Barker, RA, Parmar, M, Studer, L, Takahashi, J. Human trials of stem cell-derived dopamine neurons for Parkinson’s disease: dawn of a new era. Cell Stem Cell. Nov 2017;21(5):569–73. doi:10.1016/j.stem.2017.09.014CrossRef Google Scholar PubMed

Jensen, MB, Yan, H, Krishnaney-Davison, R, Al Sawaf, A, Zhang, SC. Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model. J Stroke Cerebrovasc Dis. May 2013;22(4):304–8. doi:10.1016/j.jstrokecerebrovasdis.2011.09.008CrossRef Google Scholar

Kikuchi, T, Morizane, A, Doi, D, et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model. Nature. Aug 2017;548(7669):592–6. doi:10.1038/nature23664CrossRef Google Scholar

Stadtfeld, M, Apostolou, E, Akutsu, H, et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature. May 2010;465(7295):175–81. doi:10.1038/nature09017CrossRef Google Scholar PubMed

Edwards, MM, Wang, N, Massey, DJ, Egli, D, Koren, A. Incomplete reprogramming of DNA replication timing in induced pluripotent stem cells. bioRxiv. 2023:2023.06.12.544654. doi:10.1101/2023.06.12.544654CrossRef Google Scholar

Kim, K, Doi, A, Wen, B, et al. Epigenetic memory in induced pluripotent stem cells. Nature. Sep 2010;467(7313):285–90. doi:10.1038/nature09342CrossRef Google Scholar PubMed

Arez, M, Eckersley-Maslin, M, Klobučar, T, et al. Imprinting fidelity in mouse iPSCs depends on sex of donor cell and medium formulation. Nat Commun. Sep 2022;13(1):5432. doi:10.1038/s41467-022-33013-5CrossRef Google Scholar PubMed

Magown, P, Brownstone, RM, Rafuse, VF. Tumor prevention facilitates delayed transplant of stem cell-derived motoneurons. Ann Clin Transl Neurol. Aug 2016;3(8):637–49. doi:10.1002/acn3.327CrossRef Google Scholar PubMed

Doi, D, Morizane, A, Kikuchi, T, et al. Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson’s disease. Stem Cells. May 2012;30(5):935–45. doi:10.1002/stem.1060CrossRef Google Scholar

Lee, MO, Moon, SH, Jeong, HC, et al. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc Natl Acad Sci USA. Aug 2013;110(35):E3281-90. doi:10.1073/pnas.1303669110CrossRef Google Scholar PubMed

Menendez, S, Camus, S, Herreria, A, et al. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. Aging Cell. Feb 2012;11(1):41–50. doi:10.1111/j.1474-9726.2011.00754.xCrossRef Google Scholar PubMed

Oh, SH, Jeong, YW, Choi, W, et al. Multimodal therapeutic effects of neural precursor cells derived from human-induced pluripotent stem cells through episomal plasmid-based reprogramming in a rodent model of ischemic stroke. Stem Cells Int. 2020;2020:4061516. doi:10.1155/2020/4061516CrossRef Google Scholar

Dräger, NM, Sattler, SM, Huang, CT-L, et al. A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states. Nature Neurosci. Sep 2022;25(9):1149–62. doi:10.1038/s41593-022-01131-4CrossRef Google Scholar

Hardiman, O, Al-Chalabi, A, Chio, A, et al. Amyotrophic lateral sclerosis. Nature Rev Dis Primers. Oct 2017;3(1):17071. doi:10.1038/nrdp.2017.71CrossRef Google Scholar PubMed

Marin, B, Boumédiene, F, Logroscino, G, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2016;46(1):57–74. doi:10.1093/ije/dyw061Google Scholar

Robberecht, W, Philips, T. The changing scene of amyotrophic lateral sclerosis. Nature Rev Neurosci. April 2013;14(4):248–64. doi:10.1038/nrn3430Google Scholar

Parobkova, E, Matej, R. Amyotrophic lateral sclerosis and frontotemporal lobar degenerations: similarities in genetic background. Diagnostics (Basel). Mar 2021;11(3). doi:10.3390/diagnostics11030509Google Scholar PubMed

Fischer, LR, Culver, DG, Tennant, P, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. Feb 2004;185(2):232–40. doi:10.1016/j.expneurol.2003.10.004CrossRef Google Scholar PubMed

Laperle, AH, Moser, VA, Avalos, P, et al. Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration. Stem Cell Reports. 2023;18(8):1629–42. doi:10.1016/j.stemcr.2023.03.016CrossRef Google Scholar PubMed

Mazzini, L, Gelati, M, Profico, DC, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. Jan 2015;13:17. doi:10.1186/s12967-014-0371-2CrossRef Google Scholar PubMed

Feldman, EL, Boulis, NM, Hur, J, et al. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann Neurol. Mar 2014;75(3):363–73. doi:10.1002/ana.24113CrossRef Google Scholar

Glass, JD, Hertzberg, VS, Boulis, NM, et al. Transplantation of spinal cord-derived neural stem cells for ALS: analysis of phase 1 and 2 trials. Neurology. Jul 2016;87(4):392–400. doi:10.1212/wnl.0000000000002889CrossRef Google Scholar

Mazzini, L, Gelati, M, Profico, DC, et al. Results from phase i clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome. Stem Cells Transl Med. Sep 2019;8(9):887–97. doi:10.1002/sctm.18-0154CrossRef Google Scholar PubMed

Riley, J, Glass, J, Feldman, EL, et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes. Neurosurgery. Jan 2014;74(1):77–87. doi:10.1227/neu.0000000000000156CrossRef Google Scholar PubMed

Riley, J, Federici, T, Polak, M, et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery. Aug 2012;71(2):405–16; discussion 416. doi:10.1227/NEU.0b013e31825ca05fCrossRef Google Scholar PubMed

Glass, JD, Boulis, NM, Johe, K, et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells. Jun 2012;30(6):1144–51. doi:10.1002/stem.1079CrossRef Google Scholar PubMed

Riley, J, Butler, J, Baker, KB, et al. Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation. Stereotact Funct Neurosurg. 2008;86(2):67–74. doi:10.1159/000112426CrossRef Google Scholar PubMed

Raore, B, Federici, T, Taub, J, et al. Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. Spine (Phila Pa 1976). Feb 2011;36(3):E164-71. doi:10.1097/BRS.0b013e3181d77a47CrossRef Google Scholar PubMed

Henderson, CE, Phillips, HS, Pollock, RA, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. Nov 1994;266(5187):1062–4. doi:10.1126/science.7973664CrossRef Google Scholar PubMed

Sareen, D, Gowing, G, Sahabian, A, et al. Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol. Aug 2014;522(12):2707–28. doi:10.1002/cne.23578CrossRef Google Scholar PubMed

Calvo, PM, Hernández, RG, de la Cruz, RR, Pastor, AM. Role of vascular endothelial growth factor as a critical neurotrophic factor for the survival and physiology of motoneurons. Neural Regen Res. Aug 2023;18(8):1691–6. doi:10.4103/1673-5374.363194Google Scholar PubMed

https://brainstorm-cell.com/pipeline/Google Scholar

Cudkowicz, ME, Lindborg, SR, Goyal, NA, et al. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. Muscle Nerve. Mar 2022;65(3):291–302. doi:10.1002/mus.27472CrossRef Google Scholar PubMed

Petrou, P, Gothelf, Y, Argov, Z, et al. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical trials. JAMA Neurol. Mar 2016;73(3):337–44. doi:10.1001/jamaneurol.2015.4321CrossRef Google Scholar PubMed

Berry, JD, Cudkowicz, ME, Windebank, AJ, et al. NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results. Neurology. Dec 2019;93(24):e2294-e2305. doi:10.1212/wnl.0000000000008620CrossRef Google Scholar

Behl, T, Kaur, G, Fratila, O, et al. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review. Transl Neurodegen. Jan 2021;10(1):4. doi:10.1186/s40035-020-00226-xCrossRef Google Scholar PubMed

Postuma, RB, Berg, D, Stern, M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Move Disord. 2015;30(12):1591–601. doi:https://doi.org/10.1002/mds.26424 CrossRef Google Scholar PubMed

Poewe, W, Seppi, K, Tanner, CM, et al. Parkinson disease. Nature Rev Dis Primers. Mar 2017;3(1):17013. doi:10.1038/nrdp.2017.13CrossRef Google Scholar PubMed

Freed, CR, Greene, PE, Breeze, RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med. Mar 2001;344(10):710–19. doi:10.1056/nejm200103083441002CrossRef Google Scholar PubMed

Olanow, CW, Goetz, CG, Kordower, JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann Neurol. Sep 2003;54(3):403–14. doi:10.1002/ana.10720CrossRef Google Scholar PubMed

Barker, RA. Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease. Nat Med. Jul 2019;25(7):1045–53. doi:10.1038/s41591-019-0507-2CrossRef Google Scholar PubMed

Kordower, JH, Chu, Y, Hauser, RA, Freeman, TB, Olanow, CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med. May 2008;14(5):504–6. doi:10.1038/nm1747CrossRef Google Scholar PubMed

Schweitzer, JS, Song, B, Herrington, TM, et al. Personalized iPSC-derived dopamine progenitor cells for Parkinson’s disease. N Engl J Med. May 2020;382(20):1926–32. doi:10.1056/NEJMoa1915872CrossRef Google Scholar PubMed

Parkinson’s iPSC trial. Nature Biotechnol. Sep 2023;41(9):1183. doi:10.1038/s41587-023-01965-8CrossRef Google Scholar

BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study https://www.bluerocktx.com/bluerocks-neuronal-stem-cell-therapy-for-parkinsons-disease-is-first-to-show-positive-results-in-phase-i-clinical-study/Google Scholar

Benjamin, EJ, Blaha, MJ, Chiuve, SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. Mar 2017;135(10):e146–603. doi:10.1161/cir.0000000000000485CrossRef Google Scholar PubMed

Dąbrowski, J, Czajka, A, Zielińska-Turek, J, et al. Brain functional reserve in the context of neuroplasticity after stroke. Neural Plast. 2019;2019:9708905. doi:10.1155/2019/9708905CrossRef Google Scholar PubMed

Hess, DC, Wechsler, LR, Clark, WM, et al. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. May 2017;16(5):360–8. doi:10.1016/s1474-4422(17)30046-7CrossRef Google Scholar

Steinberg, GK, Kondziolka, D, Wechsler, LR, et al. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study. J Neurosurg. Nov 2018:1–11. doi:10.3171/2018.5.Jns173147CrossRef Google Scholar

Stroemer, P, Patel, S, Hope, A, Oliveira, C, Pollock, K, Sinden, J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair. Nov 2009;23(9):895–909. doi:10.1177/1545968309335978CrossRef Google Scholar

Baron, JC. Protecting the ischaemic penumbra as an adjunct to thrombectomy for acute stroke. Nat Rev Neurol. Jun 2018;14(6):325–37. doi:10.1038/s41582-018-0002-2CrossRef Google Scholar

Ercelen, N, Karasu, N, Kahyaoglu, B, et al. Clinical experience: outcomes of mesenchymal stem cell transplantation in five stroke patients. Front Med (Lausanne). 2023;10:1051831. doi:10.3389/fmed.2023.1051831CrossRef Google Scholar PubMed

Berlet, R, Anthony, S, Brooks, B, et al. Combination of stem cells and rehabilitation therapies for ischemic stroke. Biomolecules. Sep 2021;11(9)doi:10.3390/biom11091316CrossRef Google Scholar PubMed

Molinares, DM, Gater, DR, Daniel, S, Pontee, NL. Nontraumatic spinal cord injury: epidemiology, etiology and management. J Pers Med. Nov 2022;12(11). doi:10.3390/jpm12111872CrossRef Google Scholar PubMed

Craig, A, Guest, R, Tran, Y, Middleton, J. Cognitive impairment and mood states after spinal cord injury. J Neurotrauma. Mar 2017;34(6):1156–63. doi:10.1089/neu.2016.4632CrossRef Google Scholar PubMed

Nakhjiri, E, Roqanian, S, Zangbar, HS, et al. Spinal cord injury causes prominent tau pathology associated with brain post-injury sequela. Mol Neurobiol. Jul 2022;59(7):4197–208. doi:10.1007/s12035-022-02843-1CrossRef Google Scholar PubMed

Xia, Y, Zhu, J, Yang, R, Wang, H, Li, Y, Fu, C. Mesenchymal stem cells in the treatment of spinal cord injury: mechanisms, current advances and future challenges. Review. Front Immunol. Feb 2023;14. doi:10.3389/fimmu.2023.1141601CrossRef Google Scholar

Scott, CT, Magnus, D. Wrongful termination: lessons from the Geron clinical trial. Stem Cells Transl Med. Dec 2014;3(12):1398–401. doi:10.5966/sctm.2014-0147CrossRef Google Scholar PubMed

Bretzner, F, Gilbert, F, Baylis, F, Brownstone, RM. Target populations for first-in-human embryonic stem cell research in spinal cord injury. Cell Stem Cells. 2011;8(5):468–75.10.1016/j.stem.2011.04.012CrossRef Google Scholar PubMed

Kim, HS, Choi, SM, Yang, W, et al. PSA-NCAM(+) neural precursor cells from human embryonic stem cells promote neural tissue integrity and behavioral performance in a rat stroke model. Stem Cell Rev Rep. Dec 2014;10(6):761–71. doi:10.1007/s12015-014-9535-yCrossRef Google Scholar

Vaquero, J, Zurita, M, Rico, MA, et al. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: safety and efficacy of the 100/3 guideline. Cytotherapy. Jun 2018;20(6):806–19. doi:10.1016/j.jcyt.2018.03.032CrossRef Google Scholar PubMed

Park, JH, Kim, DY, Sung, IY, et al. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery. May 2012;70(5):1238–47; discussion 1247. doi:10.1227/NEU.0b013e31824387f9CrossRef Google Scholar PubMed

Tran, AP, Warren, PM, Silver, J. New insights into glial scar formation after spinal cord injury. Cell Tissue Res. Mar 2022;387(3):319–36. doi:10.1007/s00441-021-03477-wCrossRef Google Scholar PubMed

Clifford, T, Finkel, Z, Rodriguez, B, Joseph, A, Cai, L. Current advancements in spinal cord injury research-glial scar formation and neural regeneration. Cells. Mar 2023;12(6). doi:10.3390/cells12060853CrossRef Google Scholar PubMed

Blanquer, M, Moraleda, JM, Iniesta, F, et al. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study. Stem Cells. Jun 2012;30(6):1277–85. doi:10.1002/stem.1080CrossRef Google Scholar PubMed

Nam, JY, Lee, TY, Kim, K, et al. Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial. Trials. May 2022;23(1):415. doi:10.1186/s13063-022-06327-4CrossRef Google Scholar PubMed

Oh, KW, Noh, MY, Kwon, MS, et al. Repeated intrathecal mesenchymal stem cells for amyotrophic lateral sclerosis. Ann Neurol. Sep 2018;84(3):361–73. doi:10.1002/ana.25302CrossRef Google Scholar PubMed

Nabavi, SM, Arab, L, Jarooghi, N, et al. Safety, feasibility of intravenous and intrathecal injection of autologous bone marrow derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: an open label phase i clinical trial. Cell J. Jan 2019;20(4):592–98. doi:10.22074/cellj.2019.5370Google Scholar PubMed

Gotkine, M, Caraco, Y, Lerner, Y, et al. Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results. J Transl Med. Feb 2023;21(1):122. doi:10.1186/s12967-023-03903-3CrossRef Google Scholar PubMed

Petrou, P, Kassis, I, Yaghmour, NE, Ginzberg, A, Karussis, D. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis. Front Biosci (Landmark Ed). Oct 2021;26(10):693–706. doi:10.52586/4980CrossRef Google Scholar PubMed

Baloh, RH, Johnson, JP, Avalos, P, et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial. Nature Med. Sep 2022;28(9):1813–22. doi:10.1038/s41591-022-01956-3CrossRef Google Scholar

Moniche, F, Gonzalez, A, Gonzalez-Marcos, JR, et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke. Aug 2012;43(8):2242–4. doi:10.1161/strokeaha.112.659409CrossRef Google Scholar PubMed

Jaillard, A, Hommel, M, Moisan, A, et al. Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial. Transl Stroke Res. Oct 2020;11(5):910–23. doi:10.1007/s12975-020-00787-zCrossRef Google Scholar PubMed

Kalladka, D, Sinden, J, Pollock, K, et al. Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet. Aug 20 2016;388(10046):787–96. doi:10.1016/s0140-6736(16)30513-xCrossRef Google Scholar

Levy, ML, Crawford, JR, Dib, N, Verkh, L, Tankovich, N, Cramer, SC. Phase I/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke. Stroke. Oct 2019;50(10):2835–41. doi:10.1161/strokeaha.119.026318CrossRef Google Scholar PubMed

Fang, J, Guo, Y, Tan, S, et al. Autologous endothelial progenitor cells transplantation for acute ischemic stroke: a 4-year follow-up study. Stem Cells Transl Med. 2018;8(1):14–21. doi:10.1002/sctm.18-0012CrossRef Google Scholar PubMed

Prasad, K, Sharma, A, Garg, A, et al. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke. Dec 2014;45(12):3618–24. doi:10.1161/strokeaha.114.007028CrossRef Google Scholar PubMed

de Celis-Ruiz, E, Fuentes, B, de Leciñana M, Alonso, et al. Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A phase II, randomized, double-blind, placebo-controlled, single-center, pilot clinical trial. Cell Transplant. 2022;31:9636897221083863. doi:10.1177/09636897221083863CrossRef Google Scholar PubMed

Muir, KW, Bulters, D, Willmot, M, et al. Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2). J Neurol Neurosurg Psychiatry. Apr 2020;91(4):396–401. doi:10.1136/jnnp-2019-322515CrossRef Google Scholar PubMed

Baak, LM, Wagenaar, N, van der Aa, NE, et al. Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study. Lancet Neurol. Jun 2022;21(6):528–36. doi:10.1016/s1474-4422(22)00117-xCrossRef Google Scholar PubMed

Gulati, A, Agrawal, N, Vibha, D, et al. Safety and efficacy of Sovateltide (IRL-1620) in a multicenter randomized controlled clinical trial in patients with acute cerebral ischemic stroke. CNS Drugs. Jan 2021;35(1):85–104. doi:10.1007/s40263-020-00783-9CrossRef Google Scholar

Suda, S, Nito, C, Ihara, M, et al. Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with Acute Ischaemic stRoke (J-REPAIR). BMJ Open. May 2022;12(5):e054269. doi:10.1136/bmjopen-2021-054269CrossRef Google Scholar PubMed

El-Kheir, WA, Gabr, H, Awad, MR, et al. Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients. Cell Transplant. Apr 2014;23(6):729–45. doi:10.3727/096368913x664540CrossRef Google Scholar PubMed

Mendonça, MV, Larocca, TF, de Freitas Souza, BS, et al. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Stem Cell Res Ther. Nov 2014;5(6):126. doi:10.1186/scrt516CrossRef Google Scholar PubMed

Satti, HS, Waheed, A, Ahmed, P, et al. Autologous mesenchymal stromal cell transplantation for spinal cord injury: a phase I pilot study. Cytotherapy. Apr 2016;18(4):518–22. doi:10.1016/j.jcyt.2016.01.004CrossRef Google Scholar PubMed

Albu, S, Kumru, H, Coll, R, et al. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study. Cytotherapy. Feb 2021;23(2):146–56. doi:10.1016/j.jcyt.2020.08.008CrossRef Google Scholar PubMed

Terrigno, M, Bertacchi, M, Pandolfini, L, et al. The microRNA miR-21 is a mediator of FGF8 action on cortical COUP-TFI translation. Stem Cell Rep. Sep 2018;11(3):756–69. doi:10.1016/j.stemcr.2018.08.002CrossRef Google Scholar PubMed

Williams, CG, Lee, HJ, Asatsuma, T, Vento-Tormo, R, Haque, A. An introduction to spatial transcriptomics for biomedical research. Genome Med. June 2022;14(1):68. doi:10.1186/s13073-022-01075-1CrossRef Google Scholar PubMed

Chung, TL, Turner, JP, Thaker, NY, et al. Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells. Stem Cells. Oct 2010;28(10):1782–93. doi:10.1002/stem.500CrossRef Google Scholar PubMed

Kubelick, KP, Emelianov, SY. In vivo photoacoustic guidance of stem cell injection and delivery for regenerative spinal cord therapies. Neurophotonics. Jul 2020;7(3):030501. doi:10.1117/1.NPh.7.3.030501CrossRef Google Scholar PubMed

Lamanna, JJ, Urquia, LN, Hurtig, CV, et al. Magnetic resonance imaging-guided transplantation of neural stem cells into the porcine spinal cord. Stereotact Funct Neurosurg. 2017;95(1):60–8. doi:10.1159/000448765CrossRef Google Scholar PubMed

Petrus-Reurer, S, Romano, M, Howlett, S, Jones, JL, Lombardi, G, Saeb-Parsy, K. Immunological considerations and challenges for regenerative cellular therapies. Comm Biol. June 2021;4(1):798. doi:10.1038/s42003-021-02237-4CrossRef Google Scholar PubMed

Mehta, RI, Carpenter, JS, Mehta, RI, et al. Ultrasound-mediated blood–brain barrier opening uncovers an intracerebral perivenous fluid network in persons with Alzheimer’s disease. Fluids Barriers CNS. June 2023;20(1):46. doi:10.1186/s12987-023-00447-yCrossRef Google Scholar PubMed

References

Bayda, S, Adeel, M, Tuccinardi, T, Cordani, M, Rizzolio, F. The history of nanoscience and nanotechnology: from chemical-physical applications to nanomedicine. Molecules. Dec 2019;25(1). doi:10.3390/molecules25010112CrossRef Google Scholar PubMed

Taniguchi, N. On the basic concept of nanotechnology. Proceeding of the ICPE. 1974.Google Scholar

Mattei, TA, Rehman, AA. “Extremely minimally invasive”: recent advances in nanotechnology research and future applications in neurosurgery. Neurosurg Rev. Jan 2015;38(1):27–37; discussion 37. doi:10.1007/s10143-014-0566-2CrossRef Google Scholar PubMed

National Nanotechnology Initiative. https://www.nano.gov/.Google Scholar

Elder, JB, Liu, CY, Apuzzo, ML. Neurosurgery in the realm of 10(-9), part 1: stardust and nanotechnology in neuroscience. Neurosurgery. Jan 2008;62(1):1–20. doi:10.1227/01.NEU.0000311058.80249.6BCrossRef Google Scholar PubMed

Elder, JB, Liu, CY, Apuzzo, ML. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery–present and future. Neurosurgery. Feb 2008;62(2):269–84; discussion 284-5. doi:10.1227/01.neu.0000315995.73269.c3Google Scholar PubMed

Iqbal, P, Preece, J, Mendes, P. nanotechnology: the “top-down” and “bottom-up” approaches. In Supramolecular Chemistry: From Molecules to Nanomaterials. https://doi.org/10.1002/9780470661345.smc1952012.CrossRef Google Scholar

Drexler, E, Peterson, C, Pergamit, G, Brand, S. Unbounding the Future: The Nanotechnology Revolution. William Morrow and Company; 1991.Google Scholar

Drexler, KE. Engines of Creation. Anchor Books; 1986.Google Scholar

Kinnear, C, Moore, TL, Rodriguez-Lorenzo, L, Rothen-Rutishauser, B, Petri-Fink, A. Form follows function: nanoparticle shape and its implications for nanomedicine. Chemic Rev. 2017;117(17):11476–521.Google Scholar PubMed

Barber, DJ, Freestone, IC. An investigation of the origin of the colour of the Lycurgus Cup by analytical transmission electron microscopy. Archaeometry. 1990;32(1):33–45.10.1111/j.1475-4754.1990.tb01079.xCrossRef Google Scholar

Mansoori, GA, Soelaiman, TF. Nanotechnology–An Introduction for the Standards Community. ASTM International; 2005.10.1520/JAI13110CrossRef Google Scholar

Pradell, T, Climent-Font, A, Molera, J, et al. Metallic and nonmetallic shine in luster: an elastic ion backscattering study. J Appl Physics. 2007;101(10):103518.10.1063/1.2734944CrossRef Google Scholar

Poole, CP, Owens, FJ. Introduction to Nanotechnology. John Wiley & Sons; 2003.Google Scholar

Reibold, M, Paufler, P, Levin, A, Kochmann, W, Pätzke, N, Meyer, D. Carbon nanotubes in an ancient Damascus sabre. Nature. 2006;444(7117):286.10.1038/444286aCrossRef Google Scholar

Binnig, G, Rohrer, H, Gerber, C, Weibel, E. Surface studies by scanning tunneling microscopy. Physical Rev Lett. 1982;49(1):57.10.1103/PhysRevLett.49.57CrossRef Google Scholar

Binnig, G, Rohrer, H, Gerber, C, Weibel, E. Tunneling through a controllable vacuum gap. Appl Physics Lett. 1982;40(2):178–80.10.1063/1.92999CrossRef Google Scholar

Binnig, G, Rohrer, H, Gerber, C, Weibel, E. 7× 7 reconstruction on Si (111) resolved in real space. Physical Review Letters. 1983;50(2):120.10.1103/PhysRevLett.50.120CrossRef Google Scholar

Eigler, DM, Schweizer, EK. Positioning single atoms with a scanning tunnelling microscope. Nature. 1990;344(6266):524–6.10.1038/344524a0CrossRef Google Scholar

Giakoumettis, D, Sgouros, S. Nanotechnology in neurosurgery: a systematic review. Childs Nerv Syst. Apr 2021;37(4):1045–54. doi:10.1007/s00381-020-05008-4.Google Scholar PubMed

Winer, JL, Kim, PE, Law, M, Liu, CY, Apuzzo, ML. Visualizing the future: enhancing neuroimaging with nanotechnology. World Neurosurg. May–Jun 2011;75(5–6):626–37; discussion 618–19. doi:10.1016/j.wneu.2011.02.016.CrossRef Google Scholar PubMed

Roco, MC. Nanotechnology: convergence with modern biology and medicine. Curr Opin Biotechnol. Jun 2003;14(3):337–46. doi:10.1016/s0958-1669(03)00068-5.CrossRef Google Scholar PubMed

Silva, GA. Introduction to nanotechnology and its applications to medicine. Surg Neurol. Mar 2004;61(3):216–20. doi:10.1016/j.surneu.2003.09.036.CrossRef Google Scholar PubMed

Leary, SP, Liu, CY, Apuzzo, ML. Toward the emergence of nanoneurosurgery: part III–nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery. Neurosurgery. Jun 2006;58(6):1009–26; discussion 1009–26. doi:10.1227/01.Neu.0000217016.79256.16.CrossRef Google Scholar PubMed

Weissig, V, Pettinger, TK, Murdock, N. Nanopharmaceuticals (part 1): products on the market. Int J Nanomed. 2014;9:4357.10.2147/IJN.S46900CrossRef Google Scholar

Wei, H, Wisniowska, A, Fan, J, et al. Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents. Proc Natl Acad Sci USA. Oct 2021;118(42). doi:10.1073/pnas.2102340118.CrossRef Google Scholar PubMed

Syed, MB, Fletcher, AJ, Forsythe, RO, et al. Emerging techniques in atherosclerosis imaging. Br J Radiol. Nov 2019;92(1103):20180309. doi:10.1259/bjr.20180309.CrossRef Google Scholar PubMed

Kwon, HJ, Shim, WH, Cho, G, et al. Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: imaging optimization and feasibility test. NMR Biomed. Jun 2015;28(6):624–32. doi:10.1002/nbm.3293.CrossRef Google Scholar PubMed

Thrippleton, M, Blair, G, Valdes-Hernandez, M, et al. MRI relaxometry for quantitative analysis of USPIO uptake in cerebral small vessel disease. Int J Molec Sci. 2019;20(3):776. doi:10.3390/ijms20030776.CrossRef Google Scholar PubMed

Pedram, MZ, Shamloo, A, Alasty, A, Ghafar-Zadeh, E. MRI-guided epilepsy detection. IEEE; 2015.10.1109/EMBC.2015.7319271CrossRef Google Scholar PubMed

Millward, JM, Ariza de Schellenberger, A, Berndt, D, et al. Application of Europium-doped very small iron oxide nanoparticles to visualize neuroinflammation with MRI and fluorescence microscopy. Neuroscience. Apr 2019;403:136–44. doi:10.1016/j.neuroscience.2017.12.014.CrossRef Google Scholar PubMed

Cho, SS, Salinas, R, Lee, JYK. Indocyanine-green for fluorescence-guided surgery of brain tumors: evidence, techniques, and practical experience. Front Surg. 2019;6:11. doi:10.3389/fsurg.2019.00011.CrossRef Google Scholar PubMed

Shahein, M, Prevedello, DM, Beaumont, TL, et al. The role of indocyanine green fluorescence in endoscopic endonasal skull base surgery and its imaging correlations. J Neurosurg. Nov 2020:1–11. doi:10.3171/2020.6.JNS192775.CrossRef Google Scholar

Shen, C, Wang, X, Zheng, Z, et al. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma. Int J Nanomed. 2019;14:101–17. doi:10.2147/IJN.S173954.Google Scholar PubMed

Eatz, TA, Eichberg, DG, Lu, VM, Di, L, Komotar, RJ, Ivan, ME. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review. J Neurooncol. Jan 2022;156(2):233–56. doi:10.1007/s11060-021-03901-9.CrossRef Google Scholar PubMed

Bobo, RH, Laske, DW, Akbasak, A, Morrison, PF, Dedrick, RL, Oldfield, EH. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA. Mar 1994;91(6):2076–80. doi:10.1073/pnas.91.6.2076.CrossRef Google Scholar PubMed

Bankiewicz, KS, Pasterski, T, Kreatsoulas, D, et al. Use of a novel ball-joint guide array for magnetic resonance imaging-guided cannula placement and convective delivery: technical note. J Neurosurg. Oct 2020:1–7. doi:10.3171/2020.6.JNS201564.CrossRef Google Scholar

Pearson, TS, Gupta, N, San Sebastian, W, et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun. Jul 2021;12(1):4251. doi:10.1038/s41467-021-24524-8.CrossRef Google Scholar PubMed

Christine, CW, Richardson, RM, Van Laar, AD, et al. Safety of AADC gene therapy for moderately advanced Parkinson disease: three-year outcomes from the PD-1101 Trial. Neurology. Jan 2022;98(1):e40–50. doi:10.1212/WNL.0000000000012952.CrossRef Google Scholar PubMed

Christine, CW, Starr, PA, Larson, PS, et al. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology. Nov 2009;73(20):1662–9. doi:10.1212/WNL.0b013e3181c29356.CrossRef Google Scholar PubMed

Mittermeyer, G, Christine, CW, Rosenbluth, KH, et al. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson’s disease. Hum Gene Ther. Apr 2012;23(4):377–81. doi:10.1089/hum.2011.220.Google Scholar PubMed

Cloughesy, TF, Petrecca, K, Walbert, T, et al. Effect of Vocimagene Amiretrorepvec in combination with flucytosine vs standard of care on survival following tumor resection in patients with recurrent high-grade glioma: a randomized clinical trial. JAMA Oncol. Dec 2020;6(12):1939–46. doi:10.1001/jamaoncol.2020.3161.CrossRef Google Scholar PubMed

Chiocca, EA, Gelb, AB, Chen, CC, et al. Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: an open-label, multi-institutional phase I trial. Neuro Oncol. Jun 2022;24(6):951–63. doi:10.1093/neuonc/noab271.CrossRef Google Scholar PubMed

Lang, FF, Conrad, C, Gomez-Manzano, C, et al. Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma. J Clinic Oncol. 2018;36(14):1419–27. doi:10.1200/jco.2017.75.8219.CrossRef Google Scholar PubMed

Desjardins, A, Gromeier, M, Herndon, JE, et al. Recurrent glioblastoma treated with recombinant poliovirus. New Engl J Med. 2018;379(2):150–61. doi:10.1056/nejmoa1716435.CrossRef Google Scholar PubMed

Kumthekar, P, Ko, CH, Paunesku, T, et al. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Sci Transl Med. Mar 2021;13(584). doi:10.1126/scitranslmed.abb3945.CrossRef Google Scholar

Andrews, DW, Judy, KD, Scott, CB, et al. Phase Ib clinical trial of IGV-001 for patients with newly diagnosed glioblastoma. Clin Cancer Res. Apr 2021;27(7):1912–22. doi:10.1158/1078-0432.CCR-20-3805.CrossRef Google Scholar PubMed

Chastagner, P, Devictor, B, Geoerger, B, et al. Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma. Cancer Chemother Pharmacol. Aug 2015;76(2):425–32. doi:10.1007/s00280-015-2781-0.CrossRef Google Scholar PubMed

Clarke, JL, Molinaro, AM, Cabrera, JR, et al. A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemother Pharmacol. Mar 2017;79(3):603–10. doi:10.1007/s00280-017-3247-3.CrossRef Google Scholar

Elinzano, H, Toms, S, Robison, J, et al. Nanoliposomal irinotecan and metronomic temozolomide for patients with recurrent glioblastoma: BrUOG329, A phase I Brown University Oncology Research Group trial. Am J Clin Oncol. Feb 2021;44(2):49–52. doi:10.1097/COC.0000000000000780.CrossRef Google Scholar PubMed

Huang, D, Zuo, Y, Li, J, et al. Bioactive composite gradient coatings of nano-hydroxyapatite/polyamide66 fabricated on polyamide66 substrates. J R Soc Interface. Jul 2012;9(72):1450–7. doi:10.1098/rsif.2011.0782.CrossRef Google Scholar PubMed

Yang, X, Chen, Q, Liu, L, et al. Comparison of anterior cervical fusion by titanium mesh cage versus nano-hydroxyapatite/polyamide cage following single-level corpectomy. Int Orthop. Dec 2013;37(12):2421–7. doi:10.1007/s00264-013-2101-4.CrossRef Google Scholar PubMed

Zhang, Y, Quan, Z, Zhao, Z, et al. Evaluation of anterior cervical reconstruction with titanium mesh cages versus nano-hydroxyapatite/polyamide66 cages after 1- or 2-level corpectomy for multilevel cervical spondylotic myelopathy: a retrospective study of 117 patients. PLoS One. 2014;9(5):e96265. doi:10.1371/journal.pone.0096265.Google Scholar PubMed

Amelot, A, Colman, M, Loret, JE. Vertebral body replacement using patient-specific three-dimensional-printed polymer implants in cervical spondylotic myelopathy: an encouraging preliminary report. Spine J. May 2018;18(5):892–9. doi:10.1016/j.spinee.2018.01.019.CrossRef Google Scholar PubMed

Girolami, M, Boriani, S, Bandiera, S, et al. Biomimetic 3D-printed custom-made prosthesis for anterior column reconstruction in the thoracolumbar spine: a tailored option following en bloc resection for spinal tumors: preliminary results on a case-series of 13 patients. Eur Spine J. Dec 2018;27(12):3073–83. doi:10.1007/s00586-018-5708-8.CrossRef Google Scholar PubMed

Garg, B, Gupta, M, Singh, M, Kalyanasundaram, D. Outcome and safety analysis of 3D-printed patient-specific pedicle screw jigs for complex spinal deformities: a comparative study. Spine J. Jan 2019;19(1):56–64. doi:10.1016/j.spinee.2018.05.001.CrossRef Google Scholar PubMed

Schon, SN, Skalicky, N, Sharma, N, Zumofen, DW, Thieringer, FM. 3D-printer-assisted patient-specific polymethyl methacrylate cranioplasty: a case series of 16 consecutive patients. World neurosurgery. Apr 2021;148:e356–62. doi:10.1016/j.wneu.2020.12.138.Google Scholar PubMed

Morales-Gomez, JA, Garcia-Estrada, E, Leos-Bortoni, JE, et al. Cranioplasty with a low-cost customized polymethylmethacrylate implant using a desktop 3D printer. J Neurosurg. Jun 2018:1–7. doi:10.3171/2017.12.JNS172574.CrossRef Google Scholar

Bendok, BR, Abi-Aad, KR, Ward, JD, et al. The Hydrogel Endovascular Aneurysm Treatment Trial (HEAT): a randomized controlled trial of the second-generation hydrogel coil. Neurosurgery. May 2020;86(5):615–24. doi:10.1093/neuros/nyaa006.CrossRef Google Scholar

White, PM, Lewis, SC, Gholkar, A, et al. Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): a randomised controlled trial. Lancet. May 2011;377(9778):1655–62. doi:10.1016/S0140-6736(11)60408-X.CrossRef Google Scholar

Raymond, J, Klink, R, Chagnon, M, et al. Patients prone to recurrence after endovascular treatment: periprocedural results of the PRET randomized trial on large and recurrent aneurysms. AJNR Am J Neuroradiol. Sep 2014;35(9):1667–76. doi:10.3174/ajnr.A4035.CrossRef Google Scholar PubMed

Taschner, CA, Chapot, R, Costalat, V, et al. GREAT-a randomized controlled trial comparing HydroSoft/HydroFrame and bare platinum coils for endovascular aneurysm treatment: procedural safety and core-lab-assessed angiographic results. Neuroradiology. Aug 2016;58(8):777–86. doi:10.1007/s00234-016-1693-y.CrossRef Google Scholar

Chuapoco, MR, Choy, M, Schmid, F, Duffy, BA, Lee, HJ, Lee, JH. Carbon monofilament electrodes for unit recording and functional MRI in same subjects. Neuroimage. Feb 2019;186:806–16. doi:10.1016/j.neuroimage.2018.10.082.CrossRef Google Scholar PubMed

He, W, Bellamkonda, RV. Nanoscale neuro-integrative coatings for neural implants. Biomaterials. Jun 2005;26(16):2983–90. doi:10.1016/j.biomaterials.2004.08.021.CrossRef Google Scholar PubMed

Hu, Z, Zhou, DM, Greenberg, R, Thundat, T. Nanopowder molding method for creating implantable high-aspect-ratio electrodes on thin flexible substrates. Biomaterials. Mar 2006;27(9):2009–17. doi:10.1016/j.biomaterials.2005.10.030.CrossRef Google Scholar PubMed

Cho, YK, Wartena, R, Tobias, SM, Chiang, YM. Self-assembling colloidal-scale devices: selecting and using short-range surface forces between conductive solids. Advanced Functional Materials. Feb 2007;17(3):379–89. doi:https://doi.org/10.1002/adfm.200600846.CrossRef Google Scholar

Kofoed Mansson, P, Johansson, S, Ziebell, M, Juhler, M. Forty years of shunt surgery at Rigshospitalet, Denmark: a retrospective study comparing past and present rates and causes of revision and infection. BMJ Open. Jan 2017;7(1):e013389. doi:10.1136/bmjopen-2016-013389.CrossRef Google Scholar

Stein, SC, Guo, W. Have we made progress in preventing shunt failure? A critical analysis. J Neurosurg Pediatr. Jan 2008;1(1):40–7. doi:10.3171/PED-08/01/040.CrossRef Google Scholar PubMed

Madsen, JR, Abazi, GS, Fleming, L, et al. Evaluation of the ShuntCheck noninvasive thermal technique for shunt flow detection in hydrocephalic patients. Neurosurgery. Jan 2011;68(1):198–205; discussion 205. doi:10.1227/NEU.0b013e3181fe2db6.CrossRef Google Scholar PubMed

Krishnan, SR, Arafa, HM, Kwon, K, et al. Continuous, noninvasive wireless monitoring of flow of cerebrospinal fluid through shunts in patients with hydrocephalus. NPJ Digit Med. 2020;3:29. doi:10.1038/s41746-020-0239-1.CrossRef Google Scholar PubMed

Elkin, T, Jiang, X, Taylor, S, et al. Immuno-carbon nanotubes and recognition of pathogens. Chembiochem. Apr 2005;6(4):640–3. doi:10.1002/cbic.200400337.CrossRef Google Scholar PubMed

Yamaguchi, T, Awano, H, Matsuda, H, Tanahashi, N, PROTECT4.5 Investigators. Edaravone with and without .6 mg/kg alteplase within 4.5 hours after ischemic stroke: a prospective cohort study (PROTECT4.5). J Stroke Cerebrovasc Dis. Apr 2017;26(4):756–65. doi:10.1016/j.jstrokecerebrovasdis.2016.10.011.CrossRef Google Scholar

Ishibashi, A, Yoshitake, Y, Adachi, H. Investigation of effect of edaravone on ischemic stroke. Kurume Med J. 2013;60(2):53–7. doi:10.2739/kurumemedj.ms62009.CrossRef Google Scholar PubMed

Dugan, LL, Gabrielsen, JK, Yu, SP, Lin, TS, Choi, DW. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis. Apr 1996;3(2):129–35. doi:10.1006/nbdi.1996.0013.CrossRef Google Scholar PubMed

Dugan, LL, Turetsky, DM, Du, C, et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci USA. Aug 1997;94(17):9434–9. doi:10.1073/pnas.94.17.9434.CrossRef Google Scholar PubMed

Liu, Y, Ai, K, Ji, X, et al. Comprehensive insights into the multi-antioxidative mechanisms of melanin nanoparticles and their application to protect brain from injury in ischemic stroke. J Am Chem Soc. Jan 2017;139(2):856–62. doi:10.1021/jacs.6b11013.Google Scholar PubMed

Shimbo, D, Abumiya, T, Kurisu, K, et al. Superior microvascular perfusion of infused liposome-encapsulated hemoglobin prior to reductions in infarctions after transient focal cerebral ischemia. J Stroke Cerebrovasc Dis. Dec 2017;26(12):2994–3003. doi:10.1016/j.jstrokecerebrovasdis.2017.07.026.CrossRef Google Scholar PubMed

Silva, GA, Czeisler, C, Niece, KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science. Feb 2004;303(5662):1352–5. doi:10.1126/science.1093783.CrossRef Google Scholar PubMed

Shang, Z, Wang, M, Zhang, B, Wang, X, Wanyan, P. Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials. BMC Med. Sep 2022;20(1):284. doi:10.1186/s12916-022-02482-2.CrossRef Google Scholar PubMed

Serafin, A, Rubio, MC, Carsi, M, et al. Electroconductive PEDOT nanoparticle integrated scaffolds for spinal cord tissue repair. Biomater Res. Nov 2022;26(1):63. doi:10.1186/s40824-022-00310-5.CrossRef Google Scholar PubMed

Yang, T, Dai, Y, Chen, G, Cui, S. Dissecting the dual role of the glial scar and scar-forming astrocytes in spinal cord injury. Front Cell Neurosci. 2020;14:78. doi:10.3389/fncel.2020.00078.CrossRef Google Scholar PubMed

Bradbury, EJ, Burnside, ER. Moving beyond the glial scar for spinal cord repair. Nat Commun. Aug 2019;10(1):3879. doi:10.1038/s41467-019-11707-7.CrossRef Google Scholar PubMed

Ellis-Behnke, RG, Liang, YX, You, SW, et al. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA. Mar 2006;103(13):5054–9. doi:10.1073/pnas.0600559103.CrossRef Google Scholar PubMed

Hu, H, Ni, Y, Montana, V, Haddon, RC, Parpura, V. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett. Mar 2004;4(3):507–11. doi:10.1021/nl035193d.CrossRef Google Scholar PubMed

Glaser, T, Han, I, Wu, L, Zeng, X. Targeted nanotechnology in glioblastoma multiforme. Front Pharmacol. 2017;8:166. doi:10.3389/fphar.2017.00166.CrossRef Google Scholar PubMed

Grabowska, M, Grzeskowiak, BF, Szutkowski, K, et al. Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme. PLoS One. 2019;14(3):e0213852. doi:10.1371/journal.pone.0213852.CrossRef Google Scholar PubMed

Lam, FC, Morton, SW, Wyckoff, J, et al. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles. Nat Commun. May 2018;9(1):1991. doi:10.1038/s41467-018-04315-4.CrossRef Google Scholar PubMed

Kanai, Y, Wang, D, Hirokawa, N. KIF13B enhances the endocytosis of LRP1 by recruiting LRP1 to caveolae. J Cell Biol. Feb 2014;204(3):395–408. doi:10.1083/jcb.201309066.CrossRef Google Scholar PubMed

Liu, L, Venkatraman, SS, Yang, YY, et al. Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. Biopolymers. 2008;90(5):617–23. doi:10.1002/bip.20998.CrossRef Google Scholar PubMed

Laquintana, V, Trapani, A, Denora, N, Wang, F, Gallo, JM, Trapani, G. New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv. Oct 2009;6(10):1017–32. doi:10.1517/17425240903167942.CrossRef Google Scholar PubMed

Chen, TC, Napolitano, GR, Adell, F, Schonthal, AH, Shachar, Y. Development of the Metronomic Biofeedback Pump for leptomeningeal carcinomatosis: technical note. J Neurosurg. Aug 2015;123(2):362–72. doi:10.3171/2014.10.JNS14343.CrossRef Google Scholar PubMed

Zheng, Y, Hunting, DJ, Ayotte, P, Sanche, L. Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiat Res. Jan 2008;169(1):19–27. doi:10.1667/RR1080.1.CrossRef Google Scholar PubMed

Xu, R, Ma, J, Sun, X, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res. Aug 2009;19(8):1031–4. doi:10.1038/cr.2009.89.CrossRef Google Scholar PubMed

Santos, T, Fang, X, Chen, MT, et al. Sequential administration of carbon nanotubes and near-infrared radiation for the treatment of gliomas. Front Oncol. 2014;4:180. doi:10.3389/fonc.2014.00180.CrossRef Google Scholar PubMed

Wang, CH, Chiou, SH, Chou, CP, Chen, YC, Huang, YJ, Peng, CA. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody. Nanomedicine. Feb 2011;7(1):69–79. doi:10.1016/j.nano.2010.06.010.CrossRef Google Scholar PubMed

Mao, X, Calero-Perez, P, Montpeyo, D, et al. Intranasal administration of catechol-based Pt(IV) coordination polymer nanoparticles for glioblastoma therapy. Nanomaterials (Basel). Apr 2022;12(7). doi:10.3390/nano12071221.CrossRef Google Scholar PubMed

Raynal, I, Prigent, P, Peyramaure, S, Najid, A, Rebuzzi, C, Corot, C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol. Jan 2004;39(1):56–63. doi:10.1097/01.rli.0000101027.57021.28.CrossRef Google Scholar PubMed

Harisinghani, MG, Barentsz, J, Hahn, PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. Jun 2003;348(25):2491–9. doi:10.1056/NEJMoa022749.CrossRef Google Scholar PubMed

Maeda, H, Wu, J, Sawa, T, Matsumura, Y, Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. Mar 2000;65(1–2):271–84. doi:10.1016/s0168-3659(99)00248-5.CrossRef Google Scholar PubMed

Cheng, Y, Morshed, RA, Auffinger, B, Tobias, AL, Lesniak, MS. Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Deliv Rev. Feb 2014;66:42–57. doi:10.1016/j.addr.2013.09.006.CrossRef Google Scholar PubMed

Tomitaka, A, Arami, H, Gandhi, S, Krishnan, KM. Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging. Nanoscale. Oct 2015;7(40):16890–8. doi:10.1039/c5nr02831 k.CrossRef Google Scholar PubMed

Finas, D, Baumann, K, Sydow, L, et al. Lymphatic tissue and superparamagnetic nanoparticles – magnetic particle imaging for detection and distribution in a breast cancer model. Biomed Tech (Berl). Aug 2013;58 Suppl 1. doi:10.1515/bmt-2013-4262.Google Scholar

Ludewig, P, Gdaniec, N, Sedlacik, J, et al. Magnetic particle imaging for real-time perfusion imaging in acute stroke. ACS Nano. Oct 2017;11(10):10480–8. doi:10.1021/acsnano.7b05784.CrossRef Google Scholar PubMed

Chalouhi, N, Jabbour, P, Magnotta, V, Hasan, D. The emerging role of ferumoxytol-enhanced MRI in the management of cerebrovascular lesions. Molecules. Aug 2013;18(8):9670–83. doi:10.3390/molecules18089670.CrossRef Google Scholar PubMed

Harting, MT, Jimenez, F, Xue, H, et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg. Jun 2009;110(6):1189–97. doi:10.3171/2008.9.JNS08158.CrossRef Google Scholar PubMed

References

Shaikhouni, A, Elder, JB. Computers and neurosurgery. World Neurosurg. 2012;78(5): 392–8. https://doi.org/10.1016/j.wneu.2012.08.020.CrossRef Google Scholar PubMed

Bartlett, J. A short history of computers. In Bartlett, J, ed. Programming for Absolute Beginners: Using the JavaScript Programming Language. Berkeley, CA: Apress; 2023: 7–16.10.1007/978-1-4842-8751-4_2CrossRef Google Scholar

Abdelwahab, MG, Cavalcanti, DD, Preul, MC. Role of computer technology in neurosurgery. Minerva Chir. 2010;65(4): 409–28.Google Scholar PubMed

Attenello, FJ, Lee, B, Yu, C, Liu, CY, Apuzzo, ML. Supplementing the neurosurgical virtuoso: evolution of automation from mythology to operating room adjunct. World Neurosurg. 2014;81(5–6): 719–29. https://doi.org/10.1016/j.wneu.2014.03.011.CrossRef Google Scholar PubMed

Bansal, GJ. Digital radiography. A comparison with modern conventional imaging. Postgrad Med J. 2006;82(969): 425–8. https://doi.org/10.1136/pgmj.2005.038448.CrossRef Google Scholar PubMed

Ganslandt, O, Behari, S, Gralla, J, Fahlbusch, R, Nimsky, C. Neuronavigation: concept, techniques and applications. Neurol India. 2002;50(3): 244–55.Google Scholar

Cho, J, Rahimpour, S, Cutler, A, Goodwin, CR, Lad, SP, Codd, P. Enhancing reality: a systematic review of augmented reality in neuronavigation and education. World Neurosurg. 2020;139: 186–95. https://doi.org/10.1016/j.wneu.2020.04.043.CrossRef Google Scholar PubMed

Enchev, Y. Neuronavigation: geneology, reality, and prospects. Neurosurg Focus. 2009;27(3): E11. https://doi.org/10.3171/2009.6.FOCUS09109.CrossRef Google Scholar PubMed

Albayrak, B, Samdani, AF, Black, PM. Intra-operative magnetic resonance imaging in neurosurgery. Acta Neurochir (Wien). 2004;146(6): 543–56; discussion 557. https://doi.org/10.1007/s00701-004-0229-0.CrossRef Google Scholar PubMed

Mertz, L. Virtual reality pioneer Tom Furness on the past, present, and future of VR in health care. IEEE Pulse. 2019;10(3): 9–11. https://doi.org/10.1109/MPULS.2019.2911808.CrossRef Google Scholar PubMed

Spicer, MA, Apuzzo, ML. Virtual reality surgery: neurosurgery and the contemporary landscape. Neurosurgery. 2003;52(3): 489–97; discussion 496–7. https://doi.org/10.1227/01.neu.0000047812.42726.56.CrossRef Google Scholar PubMed

Clarke, DB, D’Arcy, RC, Delorme, S, et al. Virtual reality simulator: demonstrated use in neurosurgical oncology. Surg Innov. 2013;20(2): 190–7. https://doi.org/10.1177/1553350612451354.CrossRef Google Scholar PubMed

Schneider, M, Kunz, C, Pal’a, A, Wirtz, CR, Mathis-Ullrich, F, Hlavac, M. Augmented reality-assisted ventriculostomy. Neurosurg Focus. 2021;50(1): E16. https://doi.org/10.3171/2020.10.FOCUS20779.CrossRef Google Scholar PubMed

Rudarakanchana, N, Van Herzeele, I, Desender, L, Cheshire, NJ. Virtual reality simulation for the optimization of endovascular procedures: current perspectives. Vasc Health Risk Manag. 2015;11: 195–202. https://doi.org/10.2147/VHRM.S46194.CrossRef Google Scholar PubMed

Waisberg, E, Ong, J, Masalkhi, M, et al. Apple Vision Pro: the future of surgery with advances in virtual and augmented reality. Ir J Med Sci. 2023. https://doi.org/10.1007/s11845-023-03457-9.CrossRef Google Scholar

Artico, M, Spoletini, M, Fumagalli, L, et al. Egas Moniz: 90 years (1927–2017) from cerebral angiography. Front Neuroanat. 2017;11: 81. https://doi.org/10.3389/fnana.2017.00081.CrossRef Google Scholar

Boulos, AS, Levy, EI, Bendok, BR, et al. Evolution of neuroendovascular intervention: a review of advancement in device technology. Neurosurgery. 2004;54(2): 438–52; discussion 452–3. https://doi.org/10.1227/01.neu.0000103672.96785.42.CrossRef Google Scholar PubMed

Luessenhop, AJ, Velasquez, AC. Observations on the tolerance of the intracranial arteries to catheterization. J Neurosurg. 1964;21: 85–91. https://doi.org/10.3171/jns.1964.21.2.0085.CrossRef Google Scholar PubMed

Teitelbaum, GP, Larsen, DW, Zelman, V, Lysachev, AG, Likhterman, LB. A tribute to Dr. Fedor A. Serbinenko, founder of endovascular neurosurgery. Neurosurgery. 2000;46(2): 462–9; discussion 469–70. https://doi.org/10.1097/00006123-200002000-00037.CrossRef Google Scholar PubMed

Crummy, AB, Strother, CM, Mistretta, CA. The history of digital subtraction angiography. J Vasc Interv Radiol. 2018;29(8): 1138–41. https://doi.org/10.1016/j.jvir.2018.03.030.CrossRef Google Scholar PubMed

Shams, T, Zaidat, O, Yavagal, D, Xavier, A, Jovin, T, Janardhan, V. Society of Vascular and Interventional Neurology (SVIN) Stroke Interventional Laboratory Consensus (SILC) Criteria: a 7 M management approach to developing a stroke interventional laboratory in the era of stroke thrombectomy for large vessel occlusions. Interv Neurol. 2016;5(1–2): 1–28. https://doi.org/10.1159/000443617.CrossRef Google Scholar

Menaker, SA, Shah, SS, Snelling, BM, Sur, S, Starke, RM, Peterson, EC. Current applications and future perspectives of robotics in cerebrovascular and endovascular neurosurgery. J Neurointerv Surg. 2018;10(1): 78–82. https://doi.org/10.1136/neurintsurg-2017-013284.CrossRef Google Scholar PubMed

Bravo, J, Wali, AR, Hirshman, BR, et al. Robotics and artificial intelligence in endovascular neurosurgery. Cureus. 2022;14(3): e23662. https://doi.org/10.7759/cureus.23662.Google Scholar PubMed

Zhao, Y, Mei, Z, Luo, X, et al. Remote vascular interventional surgery robotics: a literature review. Quant Imaging Med Surg. 2022;12(4): 2552–74. https://doi.org/10.21037/qims-21-792.CrossRef Google Scholar PubMed

Mendes Pereira, V, Rice, H, De Villiers, L, et al. Evaluation of effectiveness and safety of the CorPath GRX robotic system in endovascular embolization procedures of cerebral aneurysms. J Neurointerv Surg. 2023. https://doi.org/10.1136/jnis-2023-020161.CrossRef Google Scholar

Sajja, KC, Sweid, A, Al Saiegh, F, et al. Endovascular robotic: feasibility and proof of principle for diagnostic cerebral angiography and carotid artery stenting. J Neurointerv Surg. 2020;12(4): 345–9. https://doi.org/10.1136/neurintsurg-2019-015763.CrossRef Google Scholar PubMed

Mendes Pereira, V, Cancelliere, NM, Nicholson, P, et al. First-in-human, robotic-assisted neuroendovascular intervention. J Neurointerv Surg. 2020;12(4): 338–40. https://doi.org/10.1136/neurintsurg-2019-015671.rep.CrossRef Google Scholar PubMed

Costa, M, Tataryn, Z, Alobaid, A, et al. Robotically-assisted neuro-endovascular procedures: single-center experience and a review of the literature. Interv Neuroradiol. 2023;29(2): 201–10. https://doi.org/10.1177/15910199221082475.CrossRef Google Scholar

Lasak, JM, Gorecki, JP. The history of stereotactic radiosurgery and radiotherapy. Otolaryngol Clin North Am. 2009;42(4): 593–9. https://doi.org/10.1016/j.otc.2009.04.003.CrossRef Google Scholar PubMed

Herff, C, Krusienski, DJ, Kubben, P. The potential of stereotactic-EEG for brain-computer interfaces: current progress and future directions. Front Neurosci. 2020;14: 123. https://doi.org/10.3389/fnins.2020.00123.CrossRef Google Scholar PubMed

Schalk, G, Leuthardt, EC. Brain-computer interfaces using electrocorticographic signals. IEEE Rev Biomed Eng. 2011;4: 140–54. https://doi.org/10.1109/RBME.2011.2172408.CrossRef Google Scholar PubMed

Bauerle, L, Palmer, C, Salazar, CA, et al. Neurosurgery for psychiatric disorders: reviewing the past and charting the future. Neurosurg Focus. 2023;54(2): E8. https://doi.org/10.3171/2022.11.FOCUS22622.CrossRef Google Scholar PubMed

Miller, A. The lobotomy patient – a decade later: a follow-up study of a research project started in 1948. Can Med Assoc J. 1967;96(15): 1095–103.Google Scholar

Scangos, KW, State, MW, Miller, AH, Baker, JT, Williams, LM. New and emerging approaches to treat psychiatric disorders. Nat Med. 2023;29(2): 317–33. https://doi.org/10.1038/s41591-022-02197-0.CrossRef Google Scholar PubMed

Luyten, L, Hendrickx, S, Raymaekers, S, Gabriels, L, Nuttin, B. Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive-compulsive disorder. Mol Psychiatry. 2016;21(9): 1272–80. https://doi.org/10.1038/mp.2015.124.CrossRef Google Scholar PubMed

Holtzheimer, PE, Husain, MM, Lisanby, SH, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry. 2017;4(11): 839–49. https://doi.org/10.1016/S2215-0366(17)30371-1.CrossRef Google Scholar PubMed

Taghva, A, Corrigan, JD, Rezai, AR. Obesity and brain addiction circuitry: implications for deep brain stimulation. Neurosurgery. 2012;71(2): 224–38. https://doi.org/10.1227/NEU.0b013e31825972ab.CrossRef Google Scholar PubMed

Gautschi, OP, Schatlo, B, Schaller, K, Tessitore, E. Clinically relevant complications related to pedicle screw placement in thoracolumbar surgery and their management: a literature review of 35,630 pedicle screws. Neurosurg Focus. 2011;31(4): E8. https://doi.org/10.3171/2011.7.FOCUS11168.CrossRef Google Scholar

Mirza, AK, Alvi, MA, Naylor, RM, et al. Management of major vascular injury during pedicle screw instrumentation of thoracolumbar spine. Clin Neurol Neurosurg. 2017;163: 53–9. https://doi.org/10.1016/j.clineuro.2017.10.011.CrossRef Google Scholar PubMed

Galetta, MS, Leider, JD, Divi, SN, Goyal, DKC, Schroeder, GD. Robotics in spinal surgery. Ann Transl Med. 2019;7(Suppl 5): S165. https://doi.org/10.21037/atm.2019.07.93.CrossRef Google Scholar PubMed

Zhang, Q, Han, XG, Xu, YF, et al. Robot-assisted versus fluoroscopy-guided pedicle screw placement in transforaminal lumbar interbody fusion for lumbar degenerative disease. World Neurosurg. 2019;125: e429–34. https://doi.org/10.1016/j.wneu.2019.01.097.CrossRef Google Scholar PubMed

Farber, SH, Pacult, MA, Godzik, J, et al. Robotics in spine surgery: a technical overview and review of key concepts. Front Surg. 2021;8: 578674. https://doi.org/10.3389/fsurg.2021.578674.CrossRef Google Scholar PubMed

Maragkos, GA, Schupper, AJ, Lakomkin, N, et al. Fluorescence-guided high-grade glioma surgery more than four hours after 5-aminolevulinic acid administration. Front Neurol. 2021;12: 644804. https://doi.org/10.3389/fneur.2021.644804.CrossRef Google Scholar PubMed

Hadjipanayis, CG, Stummer, W. 5-ALA and FDA approval for glioma surgery. J Neurooncol. 2019;141(3): 479–86. https://doi.org/10.1007/s11060-019-03098-y.CrossRef Google Scholar PubMed

Suero Molina, E, Hellwig, SJ, Walke, A, Jeibmann, A, Stepp, H, Stummer, W. Development and validation of a triple-LED surgical loupe device for fluorescence-guided resections with 5-ALA. J Neurosurg. 2021: 1–9. https://doi.org/10.3171/2021.10.JNS211911.CrossRef Google Scholar

Li, KW, Nelson, C, Suk, I, Jallo, GI. Neuroendoscopy: past, present, and future. Neurosurg Focus. 2005;19(6): E1. https://doi.org/10.3171/foc.2005.19.6.2.Google Scholar PubMed

Atteya, MME. Innovations and new technologies in pediatric neurosurgery. Childs Nerv Syst. 2021;37(5): 1471–2. https://doi.org/10.1007/s00381-021-05144-5.CrossRef Google Scholar PubMed

Tu, Q, Chen, H, Ding, HW, et al. Three-dimensional printing technology for surgical correction of congenital scoliosis caused by hemivertebrae. World Neurosurg. 2021;149: e969–81. https://doi.org/10.1016/j.wneu.2021.01.063.CrossRef Google Scholar PubMed

Randazzo, M, Pisapia, JM, Singh, N, Thawani, JP. 3D printing in neurosurgery: a systematic review. Surg Neurol Int. 2016;7(Suppl 33): S801–9. https://doi.org/10.4103/2152-7806.194059.Google Scholar PubMed

Ghizoni, E, de Souza, J, Raposo-Amaral, CE, et al. 3D-printed craniosynostosis model: new simulation surgical tool. World Neurosurg. 2018;109: 356–61. https://doi.org/10.1016/j.wneu.2017.10.025.CrossRef Google Scholar PubMed

Polce, EM, Kunze, KN. A guide for the application of statistics in biomedical studies concerning machine learning and artificial intelligence. Arthroscopy. 2023;39(2): 151–8. https://doi.org/10.1016/j.arthro.2022.04.016.CrossRef Google Scholar PubMed

Bzdok, D, Altman, N, Krzywinski, M. Statistics versus machine learning. Nat Methods. 2018;15(4): 233–4. https://doi.org/10.1038/nmeth.4642.CrossRef Google Scholar PubMed

Senders, JT, Zaki, MM, Karhade, AV, et al. An introduction and overview of machine learning in neurosurgical care. Acta Neurochir (Wien). 2018;160(1): 29–38. https://doi.org/10.1007/s00701-017-3385-8.CrossRef Google Scholar PubMed

Hale, AT, Riva-Cambrin, J, Wellons, JC, et al. Machine learning predicts risk of cerebrospinal fluid shunt failure in children: a study from the hydrocephalus clinical research network. Childs Nerv Syst. 2021;37(5): 1485–94. https://doi.org/10.1007/s00381-021-05061-7.CrossRef Google Scholar PubMed

Paliwal, N, Jaiswal, P, Tutino, VM, et al. Outcome prediction of intracranial aneurysm treatment by flow diverters using machine learning. Neurosurg Focus. 2018;45(5): E7. https://doi.org/10.3171/2018.8.FOCUS18332.CrossRef Google Scholar PubMed

Senders, JT, Arnaout, O, Karhade, AV, et al. Natural and artificial intelligence in neurosurgery: a systematic review. Neurosurgery. 2018;83(2): 181–92. https://doi.org/10.1093/neuros/nyx384.CrossRef Google Scholar PubMed

Chiang, S, Levin, HS, Haneef, Z. Computer-automated focus lateralization of temporal lobe epilepsy using fMRI. J Magn Reson Imaging. 2015;41(6): 1689–94. https://doi.org/10.1002/jmri.24696.CrossRef Google Scholar PubMed

Thirunavukarasu, AJ, Ting, DSJ, Elangovan, K, Gutierrez, L, Tan, TF, Ting, DSW. Large language models in medicine. Nat Med. 2023;29(8): 1930–40. https://doi.org/10.1038/s41591-023-02448-8.CrossRef Google Scholar PubMed

Liu, J, Zheng, J, Cai, X, Wu, D, Yin, C. A descriptive study based on the comparison of ChatGPT and evidence-based neurosurgeons. iScience. 2023;26(9): 107590. https://doi.org/10.1016/j.isci.2023.107590.CrossRef Google Scholar PubMed

Ali, R, Tang, OY, Connolly, ID, et al. Performance of ChatGPT and GPT-4 on neurosurgery written board examinations. Neurosurgery. 2023;93(6): 1353–65. https://doi.org/10.1227/neu.0000000000002632.Google Scholar PubMed

Sevgi, UT, Erol, G, Dogruel, Y, Sonmez, OF, Tubbs, RS, Gungor, A. The role of an open artificial intelligence platform in modern neurosurgical education: a preliminary study. Neurosurg Rev. 2023;46(1): 86. https://doi.org/10.1007/s10143-023-01998-2.CrossRef Google Scholar PubMed

Oermann, EK, Kondziolka, D. On chatbots and generative artificial intelligence. Neurosurgery. 2023;92(4): 665–6. https://doi.org/10.1227/neu.0000000000002415.CrossRef Google Scholar PubMed

D’Amico, RS, White, TG, Shah, HA, Langer, DJ. I asked a ChatGPT to write an editorial about how we can incorporate chatbots into neurosurgical research and patient care. Neurosurgery. 2023;92(4): 663–4. https://doi.org/10.1227/neu.0000000000002414.Google Scholar PubMed

Barker, FG, Rutka, JT. Editorial. Generative artificial intelligence, chatbots, and the Journal of Neurosurgery Publishing Group. J Neurosurg. 2023;139(3): 901–3. https://doi.org/10.3171/2023.4.JNS23482.CrossRef Google Scholar PubMed

Kuang, YR, Zou, MX, Niu, HQ, Zheng, BY, Zhang, TL, Zheng, BW. ChatGPT encounters multiple opportunities and challenges in neurosurgery. Int J Surg. 2023;109(10): 2886–91. https://doi.org/10.1097/JS9.0000000000000571.CrossRef Google Scholar PubMed

Rudolph, J, Tan, S, Tan, S. War of the chatbots: Bard, Bing Chat, ChatGPT, Ernie and beyond. The new AI gold rush and its impact on higher education. J Appl Learn Teach. 2023;6(1).Google Scholar

Raju, B, Jumah, F, Ashraf, O, et al. Big data, machine learning, and artificial intelligence: a field guide for neurosurgeons. J Neurosurg. 2020: 1–11. https://doi.org/10.3171/2020.5.JNS201288.CrossRef Google Scholar

Palmisciano, P, Jamjoom, AAB, Taylor, D, Stoyanov, D, Marcus, HJ. Attitudes of patients and their relatives toward artificial intelligence in neurosurgery. World Neurosurg. 2020;138: e627–33. https://doi.org/10.1016/j.wneu.2020.03.029.CrossRef Google Scholar PubMed

Rowland, NC, Breshears, J, Chang, EF. Neurosurgery and the dawning age of brain-machine interfaces. Surg Neurol Int. 2013;4(Suppl 1): S11–14. https://doi.org/10.4103/2152-7806.109182.Google Scholar PubMed

Lorach, H, Galvez, A, Spagnolo, V, et al. Walking naturally after spinal cord injury using a brain-spine interface. Nature. 2023;618(7963): 126–33. https://doi.org/10.1038/s41586-023-06094-5.CrossRef Google Scholar PubMed

Buch, E, Weber, C, Cohen, LG, et al. Think to move: a neuromagnetic brain-computer interface (BCI) system for chronic stroke. Stroke. 2008;39(3): 910–17. https://doi.org/10.1161/STROKEAHA.107.505313.CrossRef Google Scholar PubMed

Murphy, DP, Bai, O, Gorgey, AS, et al. Electroencephalogram-based brain-computer interface and lower-limb prosthesis control: a case study. Front Neurol. 2017;8: 696. https://doi.org/10.3389/fneur.2017.00696.CrossRef Google Scholar PubMed

Kotchetkov, IS, Hwang, BY, Appelboom, G, Kellner, CP, Connolly, ES, Jr. Brain-computer interfaces: military, neurosurgical, and ethical perspective. Neurosurg Focus. 2010;28(5): E25. https://doi.org/10.3171/2010.2.FOCUS1027.CrossRef Google Scholar PubMed

Vasiljevic, GAM, Cunha de Miranda, L. The CoDIS taxonomy for brain-computer interface games controlled by electroencephalography. Int J Hum–Comput Interact. 1–28. https://doi.org/10.1080/10447318.2023.2203006.CrossRef Google Scholar

Childs, S, Bruch, P. Successful management of risk in the hybrid OR. AORN J. 2015;101(2): 223–34; quiz 235–7. https://doi.org/10.1016/j.aorn.2014.04.020.CrossRef Google Scholar PubMed

Waisberg, E, Ong, J, Masalkhi, M, et al. The future of ophthalmology and vision science with the Apple Vision Pro. Eye (Lond). 2023. https://doi.org/10.1038/s41433-023-02688-5.CrossRef Google Scholar

Chidambaram, S, Stifano, V, Demetres, M, et al. Applications of augmented reality in the neurosurgical operating room: a systematic review of the literature. J Clin Neurosci. 2021;91: 43–61. https://doi.org/10.1016/j.jocn.2021.06.032.CrossRef Google Scholar PubMed

Accessibility standard: Inaccessible, or known limited accessibility

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

The HTML of this chapter is known to have missing or limited accessibility features. We may be reviewing its accessibility for future improvement, but final compliance is not yet assured and may be subject to legal exceptions. If you have any questions, please contact accessibility@cambridge.org.

Content Navigation

Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.

Index navigation
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.

Reading Order & Textual Equivalents

Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.

Short alternative textual descriptions
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.

Visual Accessibility

Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.

Structural and Technical Features

ARIA roles provided
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.

Book contents

Section III - Areas of Biological and Technical Advances Driving Neurosurgical Innovation

Information

Access options

Book purchase

Temporarily unavailable

References

References

References

References

References

Accessibility standard: Inaccessible, or known limited accessibility

Why this information is here

Accessibility Information

Content Navigation

Reading Order & Textual Equivalents

Visual Accessibility

Structural and Technical Features

Save book to Kindle

Save book to Dropbox

Save book to Google Drive